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Introduction: Biologically active supplements (BASs) market is increasing in many 
countries. However, the data on the consumption of BASs is still limited. In the growing 
market, the pattern of using BASs increased in the Kyrgyz Republic. Expansion the cases of 
detection substandard and falsified of BASs in Kyrgyzstan should be noted that crisis in the 
regulation system of BASs and lack of awareness among the population, like these relevant 
issues have prompted to study this research. The study aims to identify consumers' attitudes 
towards BASs and assess BAS's knowledge among the Kyrgyz Republic population, and 
study Kyrgyzstan's regulation system compared to the Republic of Korea. 
Materials and methods: As a general method for this study has been used as a qualitative 
approach. In achieving the research objectives, the data collected from both primary and 
secondary sources were used. The study's primary data was collected through an online- 
questionnaire based on BAS use among consumers and non-consumers of the study 
population. The total number of participants was 372. The secondary resources used the data 
and the necessary documents for the research from the Kyrgyzstan government and the 
Korean government on the regulation system of BASs and health functional food. 
Results: Prevalence of use of BASs among the population is high. 72.0% of participants 
were consumers, and 28.0% were non-consumers. Among them, 69.9% were female, and 
30.1% were male. Identified: a statistically significant difference between males and females 
using BASs, a significant difference in knowledge between BAS consumers and non-
consumers, and a strong association between BASs and the government regulation.  
The study of regulation on HFFs in the Republic of Korea recommended the appropriate 
functions for regulating the BAS in Kyrgyzstan.
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Conclusion: The current results emphasize the compelling need for spreading public 
awareness in the Kyrgyz Republic regarding biologically active supplements. Consumers 
should be advised that BAS products may not always be beneficial and can cause serious side 
effects; therefore, consulting with healthcare professionals before starting any supplement. 
All multidisciplinary healthcare structure members should also clearly understand the 
potential hazards and benefits of BAS therapies.  
The government needs to make the biologically active supplement market more transparent 
and strict regulation system on the registration process and distribution channels. 





1.1. Definition and critical terms of the biologically active supplements (BASs) 
Nutrition is one of the most critical factors mediating connecting a person with the 
external environment and determining general health status.                                   
Biologically active supplements also called vitamin supplements or dietary supplements, 
is one of the most popular consuming these days in every part of the world. Biologically 
Active Supplements (BASs) are the products containing nutrient and (or) biologically 
active substances (their concentrates) of natural or artificial origin (identical to the 
natural), as well as prebiotic components and probiotic microorganisms, which are meant 
to be taken at the same time with food for optimization of human ration and which are not 
the only source of food or dietary nutrition [1]. 
There are three categories of BAS: 
•    Nutraceuticals - biologically active food supplements are applied to correct a chemical 
compound of food. It is an additional source nutrient: fiber, amino acids, fats, 
carbohydrates, vitamins, mineral substances. 
•    Parapharmaceutics – substances that contain the raw extracts and the vegetable 
formulas (phytopreparations). They can be applied to preventive maintenance, auxiliary 
therapy, and maintenance of functional activity of body systems. For instance, commonly 
used as organic acids, flavonoids, caffeine, biogenic amines, regulatory di- and 
oligopeptides, some oligosaccharides and, many others, so-called natural products.                                                             
•    Probiotics – live sufficient bacteria which restores natural micro flora of the body [2].                         
The primary function is to “adequate consumption of the BAS that is the daily 
consumption level of nutrient and biologically active substances, established based on 
calculated and observed quantities or levels of consumption of, nutrient and biologically 
active substances by a group/groups of almost healthy people. The “norms of 
physiological need” is an averaged amount of the necessary intake of nutrients and 
biologically active substances, which ensure the optimal realization of physiological and 
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biochemical processes inherent to human genotype. 
Foodstuffs shall satisfy human physiological needs in necessary substances and energy, 
comply with requirements usually set for foodstuffs in terms of organoleptic, physical 
and chemical indices and conform with the requirements established by normative 
documents for allowed content of chemical, biologically active substances and their 
compounds, microorganisms and other organisms posing a danger for the health of 
present and future generations [1].  
The primary purposes for using biologically active supplements are:  
- For fast deficiency completion of biologically active substances that do not arrive in 
sufficient quantities. Their level can be lowered and can cause immunity system 
weakness. Often our body needs more amino acids, poly-nonsaturated fat acids, vitamins, 
macrocells and microcells, food fibers, ect.  
- For resistibility, increase of an organism. Using BAS, we can decrease the damage to 
environmental factors. For these purposes is generated phytogenesis products based on 
ginseng ginger, pink rodiola etc. 
- For preventive maintenance of infringement of metabolism processes. BAS can also be 
used for chronic disease prevention;   
- For the restoration of immunity system; 
- For deducting of toxins and radionuclides from organism [2].  
Effectiveness of using BAS is a very relative question. Many specialists think very 
skeptically about BAS, but some conduct clinical trials to prove its effectiveness. Some 
the active forms of vitamins and minerals can substantially benefit health and can often is 
the distinguishing factor between a mild effect and a profound shift in health.  
1.2. Background of the study 
Biological active supplements have a long history. In the beginning, used herbal 
plants as an extract then based on the theories, beliefs, and experiences indigenous to 
different cultures, whether explicable or not, used in the maintenance of health, as well as 
in the prevention, diagnosis, improvement, or treatment of physical and mental illnesses.  
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Since that period, the term biologically active supplement used interchangeably with 
complementary/ alternative/ conventional medicine. 
Today no global consensus on how the category of products known variously as 
removing biologically active  supplements (BASs), natural health products (NHPs), 
complementary medicines, Health Functional Food (HFFs), or  food supplements in 
different countries are defined. For example, a product considered to be a biologically 
active supplement and regulated as a food in the Kyrgyz Republic, in another jurisdiction 
may be considered a food supplement or a therapeutic good (complementary medicine or 
prescription medicine) or potentially even a controlled substance. 
The other side is that while all regulatory scientists want to protect consumers from harm, 
ensure that consumers can make informed choices about the products they use, and do the 
right thing, the scientific challenges and regulatory systems that have emerged to address 
them vary significantly to country. Even in countries with similar cultures, legal systems, 
and economic development levels, the rules applied to dietary supplements vary 
significantly. Some of these differences are discussed below: in Australia, Canada, and 
the United States, all English-speaking countries with broadly similar cultures and legal 
systems, to illustrate this point. In other countries with similar legal systems, such as the 
United Kingdom, New Zealand, and South Africa, or other countries in the Americas, 
Europe, Africa, and Asia, often with different cultures, legal systems, and levels of 
economic development, is left to the discretion of others with a lot of experience and 
knowledge. 
Also, the health products "dietary supplements" are often a very emotional topics that 
evokes a wide variety of opinions and points of view. While some observers may argue 
that these products should be treated as common medicines and foods, others believe that 
a more individual approach is needed. There is often a traditional or historical evidence 
base, and products often contain multiple ingredients. This situation is becoming 
increasingly difficult due to the lucrative nature of the global dietary supplement sector, 
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the increased involvement of the growing industrial sector that produces them, and many 
new and innovative products to the market. 
The Biological active supplement market has become more global and lucrative, so 
it has the importance of ensuring product quality and it is challenges. In the last decades 
in Kyrgyzstan,  the turnover of BASs is becoming one of the most dynamically 
developing sectors on the pharmaceutical market, and this market has been developing 
since 2007. The consumption of BAS is very different by countries. In the U.S., more 
than 80% of the population consumes BAS and in Europe, it is 50%. In Kyrgyzstan, 
according to the marketing companies Neman-Pharma, Bimed-Pharm ect. the consumer 
number around 12%-14% in a year regarding the statistics it is substantial growth. The 
demand for BAS is growing because they are relatively easy to develop, produce, and 
register than pharmaceuticals. More progress can be expected because of the growth of 
pharmacy chains and the government’s stricter regulations on the registration process and 
distribution channels. In the market of BAS products in Kyrgyzstan, import products are 
more dominant than domestic. 
1.3. Statement of the problem and significance of the study  
The biologically active suplement as nutritive substances and minor food 
components is used to ameliorate vitamins in organisms, decrease the risk of debilitating 
diseases, and improve life quality. It exerts their effect by stimulating universal 
mechanisms of the adaptation-adjustment response of the body to various external and 
internal factors. At the same time, quantitative changes of parameters of body system 
functioning are within their physiological boundaries.  
Some dietary supplements are formulated under careful conditions in clean, controlled 
laboratories and labeled accurately. Others are made less carefully and have been found 
to contain none of the substances listed on their labels. Furthermore, many supplements 
contain other substances that are not listed on their labels – fillers, different herbs, or 
actual drugs that are known to be able to cause harm. Such cases are relevant issues in 
Kyrgyzstan, and this study summarizes some of the challenges in biological active 
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supplement science in the Kyrgyz Republic. The main reason for the study: in connection 
with the expansion of the range of detection substandard and falsified of BASs and the 
low level of control among regulators including regulating through health, safety 
legislation, quality of composition, effectiveness and label content requirement using of 
it. Such as issues proposed to explore this scrutiny by revealing these problems: 
- Because of increasing cases of detection substandard and falsified biologically active 
supplements in Kyrgyzstan should be noted that crisis in the regulation system of BAS; 
- Lack of knowledge about BASs among populations because of misusing it by self-
treatment method without any doctor’s consultation, even for unusual diseases. Such in 
cases to replace drugs with BASs and also to try to cure the disease cannot be 
categorically impossible;  
- Lack of harmonization of current technical regulations by worked out European 
Economic Union (EEU-agreement between Russia, Kazakhstan, Armenia, Belarus, and 
Kyrgyzstan): arising disagreement in the interpretation of concepts and requirements of 
biologically active supplements in confirmation of conformity.  
Since 2017 the Kyrgyz Republic ensures the regulation of BASs that comply with 
the requirements of the technical regulations, such as: TR CU 021/2011 Article 24 
“About Safety of foods”on its territory without presenting additional requirements for 
BAS and without conducting additional conformity assessment procedures. According to 
the EEU decree, most the BASs approve based on manufacturing certificates by the 
Department of Disease Prevention and State Sanitary and Epidemiological Surveillance 
of the Kyrgyz Republic.  
In Kyrgyzstan, a review of the literature indicates limited published consumer research 
data and no recent studies on manufacturers on active biological supplements. Hence, in 
an attempt to address this gap, the investigation will undertake to:  
1. Determine the current control system of BASs based on registration procedures; 
2. Identify the practices and attitudes of selected consumers and non-consumer towards   
active biological supplements; 
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3. Comparision of the regulation system in Kyrgyzstan and the Republic of Korea. 
Based on the results of the studies will develop recommendations for the population to 
optimize the use of BASs and will help improve the public health issue in the BAS sector 
in the Kyrgyz Republic. 
1.4. Hypotheses  of the study  
Set 1: Males and females will differ in the use of the biologically active supplements. 
H0: There is equal use of BAS products among females and males. 
HA: There is a significant difference by gender in the use of BAS. 
Set 2: Knowledge of biologically active supplements will differ between users and non-
users. 
H0: There is no significant difference BAS knowledge among users and non-users group.  
HA: There is a significant difference BAS  knowledge among users and non-users group. 
Set 3: There is an association between the use of BAS among the population and the 
government regulation. 
H0: There is no association between the use of BAS and government regulation. 
HA: There is an association between the use of BAS and the government regulation. 
 *H0 - Null Hypothesis  












REVIEW OF LITERATURE 
2.1. Progress on biologically active supplements in the field of medicine 
There was limited scientific research on dietary supplements relatively recently, and 
so little was known about them [2]. From the immemorial time the plants have been used 
not only for food but also as a source of biologically active substances. The use of plants 
for medicinal purposes was documented in Sumerian manuscripts more than 5000 years 
ago. The substances of plant origin were for long the only source of medical drugs [3]. 
However, even presently, these substances are extensively used in the health care 
practice. The discovery and exploration of alkaloids opened the way to obtaining 
chemically uniform monomolecular medicines of natural origin [4]. Even in the era of 
combinatory chemistry, more than 25% of new medicinal agents are related to plant 
origin substance [5]. The rapidly growing application of preparations from sweet 
wormwood (Artemisia annua L.) in the struggle against malaria [6] is a demonstrative 
example of herbal medicines effectiveness.  Interactions of chemical components in the 
extracts play an important role in the effectiveness of plant preparations. For instance, an 
alkaloid triptolide from Tripterygium wilfordii, useful for rheumatoid arthritis therapy is 
highly toxic for humans in purified form. However, the toxicity of non-purified triptolide 
in plant extracts is significantly reduced [7]. The effectiveness of non-purified plant 
preparations, as compared to that of purified ingredients, might involve other mechanisms 
such as protection of active substance from the attack of “foreign” enzymes, a faster 
transfer of the active substance across membranes, and circumvention of drug resistance 
of human organisms. Presently, there is a growing interest in mechanisms underlying 
plant-derived substances the action  on gene activities involved in disease development or 
vital functions of the organism [8]. 
According to estimates of the World Health Organization (WHO), about 80% of the 
developing countries  population relies on plant preparations in the therapy of diseases, 
and the number of Member States regulating herbal medicines increased with national 
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research institutions [9]. Traditionally, plant preparations are widely used in 
pharmacopeias of Japan, Korea, the USA, Germany, and other European countries. In 
Kyrgyzstan, medicinal plant preparations were allowed for registration not long ago; 
however, most such preparations are widely used among the population. In many 
countries globally bioactive preparations of natural origin are also widely applied as 
biologically active supplements (nutraceuticals).   According from the Food and 
Agriculture Organization (FAO) data, more than 50000 plant species are used in 
traditional folk medicine throughout the world. The highest developing percentage of 
native flora species used for medication is observed in Southeast Asia countries, such as 
India (20%) and China (19%). In the United States and Russia, slightly more than 10% of 
plant species are used for therapeutic purposes.                                              
The chemical diversity of the plant kingdom remains mostly unexplored. Even less 
is known about the biological activity of chemical substances obtained from plants. Our 
planet’s diverse and unique flora is an enormous source of prospects for biotherapy and 
improvement of public health care. However, the boosted research and implementation of 
methods for obtaining medicinal agents from natural raw materials are directly related to 
biodiversity conservation problem [10]. Because of the changing environmental sphere, it 
has directly affected natural resources used as herbals for healing in medicine. Through 
the technological items, diversity of BAS is extensively growing in the world.     
2.2. Prevalence use of biologically active supplements around the world 
Weiyan Gong et al. investigated the prevalence of the nutrient supplement use 
among the Chinese population aged 6 years and older in 2010–2012. A stratified 
multistage cluster sampling method was conducted to recruit participants from 150 
surveillance sites through an interview-administrative questionnaire. A total of 74,501 
children and adults (excluding the pregnant women) were included in the study (mean 
age, 35.7 years; male, 47.0%, female, 53.5%). Very few of the participants reported using 
nutrient supplements in the previous month. Participants aged 6–11 years and above 60 
years, female, living in large urban, with higher education levels and higher family 
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incomes, were more likely to use nutrient supplements than their counterparts. The 
prevalence of nutrient supplement use increased with age in Chinese adults. The highest 
usage among the nutrient supplements was multi-vitamins and minerals. More females 
used single vitamin, multi-mineral, multi-vitamins, and minerals than males. The nutrient 
supplement use proportion was highest amongst the participants with a health problem. 
The participants who had no idea about their health conditions were the least likely to use 
the nutrient supplements (p < 0.05). According the results of this study , further research 
is required to understand the social cognition, usage reasons, dosage and consumption 
motivation of NS, and the relationships with health effects, to ensure that the nutrient 
supplements can be appropriately promoted in China [11]. 
Alissa J. Burnett et al. revealed supplement use among populations in Australia that 
limited studies examine the characteristics of people who take supplements. Investigated 
the demographics, lifestyle habits, and health status of supplement users; Adults aged >19 
years (n=4895) were included from the 2011–2012 National Nutrition and Physical 
Activity Survey (NNPAS). A supplement user was defined as anyone who took one or 
more supplements on two 24-h dietary recalls. Supplement use was reported by 47% of 
women and 34% of men, and supplement use was higher among older age groups, among 
those with higher education levels and, areas reflecting the least socioeconomic 
disadvantaged. An association was found between blood pressure and supplement use 
and, a substantial proportion of Australians take supplements. The study recommended 
further investigation into the social, psychological, and economic determinants that 
motivate the use of supplements is required to ensure the appropriate use of supplements 
among Australian  
adults [12]. 
S. Schwab et al. investigated patterns, prevalence, and determinants of DS use in 
aged among population-based face-to-face surveys in Europe. The age-standardized 
prevalence of DS intake was 54.3% in women and 33.8% in men, respectively. The most 
commonly supplemented mineral and vitamin, respectively, was magnesium (31.9%) and 
10 
 
vitamin D (21.5%) in women and magnesium (18.0%) and vitamin E (12.0%) in men. 
Compared to the German Dietary Reference Intakes, the highest were reported for biotin, 
vitamin B6 and B1. Excessive intakes (equal to or above the European Tolerable Upper 
Intake Levels (UL)) were observed especially for magnesium and vitamin E. 20.2% of 
the women and 32.5% of the men who took magnesium supplements regularly exceeded 
the UL for magnesium. DS use determinants were sex, education, smoking, physical 
activity, neurological diseases, and stroke. A high proportion of the general population 
aged 65 years and older in Southern Germany uses DS, especially supplements 
containing vitamins/minerals. The consumption of vitamin D can be regarded as 
favorable in this age group, whereas the excessive intake of vitamin E might be a cause of 
concern. [13]. 
Marinac J.S. et al. surveyed Americans aged approximately 60 years and older 
regarding their use of herbal products, dietary supplements and their attitudes and 
knowledge regarding the safety of these popular substances. A face-to-face, 35-item 
survey was administered to the population 267 residing in the Kansas City, Mo-
metropolitan area. Researchers documented usage patterns for, attitudes about, and 
knowledge of herbal products and dietary supplements in this population. At that 
moment, 21% respondents took at least one herbal product or dietary supplement, and the 
potential for adverse drug reactions was apparent in 19% (2012). Glucosamine, garlic, 
Echinacea, and Gingko Biloba were the most frequently cited substances used by survey 
participants. White women with at least some college education were most likely to 
report taking these products. However, preservation of health was by far the most 
predictive indicator for use of herbal products and dietary supplements. Subjects were 
found that substantial misconceptions about herbal products and dietary supplements 
exist among older Americans. Most individuals in this population are interested in 
receiving additional information about these products [14].  
Mashael A. and Manal A. determined the characteristics and lifestyle choices of 
dietary supplement users and to assess knowledge, attitude, and practice related to dietary 
11 
 
supplements in the health sciences students versus other individuals in Saudi Arabia by a 
descriptive cross-sectional method through on online questionnaire-based study including 
351 participants (138 were health sciences students and 203 were not). More than half of 
the participants consumed dietary supplements, 53.6% of the health sciences students 
versus 56.3% of the other individuals. Multivitamins were the most commonly used 
supplement in all participants. Both groups believed that people might need dietary 
supplements more during specific times as pregnancy or recovery from diseases, with a 
higher percentage in health sciences students than other people (43% versus 38%). A 
significant difference (P ≤ 0.05) was found concerning opinion and beliefs related to DSs 
between the two groups. The users of dietary supplements tend to incorporate these 
products into their lifestyles as part of a broader focus on healthy living. Many health 
sciences students do not have accurate information about dietary supplements. It is 
important to strengthen the health science curriculum concerning this topic, to producing 
better-informed future professionals [15].  
Kyrgyzstan, the development of research on biologically active supplements has not 
received due attention. The weak level of development of the quality control system in 
the regulation leads to erroneous results that significantly affect public health. According 
to evidence–based medicine experts, the prevalence use of dietary supplements among 
the population is high because of  inaccurate information among the population recorded 
misusing of these products. It needed research on it and provided reliable and accessible 
information about the use of biologically active supplements [16].      
2.3. Importance of the quality of biologically active supplements 
The first step in characterizing supplement products is generally identifying the 
ingredients [17]. Plant identification is a particular challenge. Even when easily identified 
whole plants or plant parts are used, unless the chain of custody is tight and the exact 
manufacturing process is known and well-characterized, the quality of extracts and blends 
such as those found in many botanical products is difficult to ascertain. Reliable 
analytical methods to characterize the bioactive components in supplements are helpful, 
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but even for the nutrients in supplements, specific analytical chemistry methods must be 
often developed [18]. Quality of botanical products is great uncertainty that consumers, 
clinicians, regulators, and researchers face, including fundamental quality parameters of 
dietary supplements such as identity, purity, and content determination. Definitions of 
quality abound, including specifications for sanitation, adventitious agents (pesticides, 
metals, weeds), and content of natural chemicals. Because dietary supplements are often 
complex mixtures, they pose analytical challenges, and method validation may be 
difficult. In response to product quality concerns and the need for validated and use 
publicly available methods, analytical standards, and reference materials for DS analysis 
[19]. The rigorous assessment of dietary supplement ingredients requires accurate, 
precise, and reliable analytical methods and matching reference materials providing 
resources for characterization and verification of supplement product content that 
enhance the reliability and reproducibility of research using these products and support 
product quality [20].     
Biologically active supplements are subject to the Department of Disease Prevention 
and State Sanitary and Epidemiological Surveillance requirements for acceptable 
manufacturing practices (cGMP) and quality control in the Kyrgyz Republic. cGMP 
requires specifications for each ingredient and approves it under the EEU Technical 
regulations. The main specific parameters are identity, purity, potency, and other 
requirements for regulatory compliance. Each parameter must be analyzed with a 
scientifically valid method. Analytical laboratory conducts specific testing on BAS within 










Table 1. The main indicators and devices for quality control of BAS 
Testing Typically testing of BAS The main devices for conducting quality 
control of BAS 
Organoleptic and physical 
characteristics (visual, color, odor, 
taste, density, transparency of 
liquids) 
Purity (absence of impurities such 
as moisture, microbiology, 
pathogens, heavy metals, residual 
solvents, pesticides) 
Pathogens (Salmonella, E. Coli, 
Staph) 
Labeling and packing 
 
Karl Fischer 
Ro-tap and particle size analysis 
Titration 
Gravimetry 
High Performance Liquid Chromatography 
(HPLC) 
Gas Chromatography with Flame Ionization 
Detection (GC-FID) 
Gas Chromatography with Mass Spectrometry 
(GC-MS) 
Inductively Coupled Plasma Mass Spectrometry 
(ICP-MS) 
Total Aerobic Plate Count 
The measurement of BASs for heavy metals is routine and usually utilizes atomic 
absorption spectroscopy or inductively coupled plasma mass spectrometry. The analysis 
of pesticide and herbicide residues in botanicals used in the preparation of dietary 
supplements should be a routine quality assurance step to help ensure human health [21]. 
Huggett et al. concluded that the presence of these pesticides at levels exceeding 20 
ng/g in botanical dietary supplements indicates the potential for hazard to human health 
depending upon the intake levels. It should be noted that the use of many of these 
pesticides is either banned or restricted in many countries, including Canada, the United 
States, and the European Union. Therefore, testing the plant material for pesticide 
residues before incorporation into dietary supplements or assaying the processed dietary 
supplement could control or eliminate this hazard if highly contaminated materials were 
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excluded from use or if the final product contained pesticide levels deemed safe for 
human consumption at the expected levels of intake [22]. 
Based on technical regulation TR CU 021-2011 “On food safety” under the 
regulation of EEU is described the paramount analytical control quality of testing: 
hygienic requirements for the safety of BAS products in the Kyrgyz Republic. The tests 
that are checking the quality of BAS products based on:  organoleptic, microbiological 
safety standards (pathogenic); toxicological; radiological; containing herbs – tests for 
pesticides; authenticity tests that prove the ingredients listed are contain; in some cases – 
tests on Genetically Modified Ingredients. Despite the importance of some of them 
Melamine, Nitrates, and Mycotoxins: Aflatoxin M1 are not available to check because of 
unlimited analytical laboratory resources, also not available documents and competence 
of personal issues. In the Appendix 7 of that Technical Regulation described lists 
components of biologically active substances, food components, and products, which can 
hurt human health when used for the manufacture of biologically active food additives[1]. 
After analytical procedures of BASs have been free from hazardous contaminants, the 
next step is to ensure a safe and reliable BAS is standardization. The primary function of 
standardization is to provide consumers with a product that contains consistent levels of 
active ingredients (chemical standardization), predictable pharmacological and 
physiological effects (biological standardization). The BAS’s repair is ensured by 
preventing accidental over dose due to variation and providing the consumer with 
predictable physiological and pharmacological efficacy. The quality control of BASs 
containing mixtures of botanicals is complicated due to the batch-to-batch variation in 
each botanical, chemical composition used in the product. If the product can be 
standardized using bioassays instead of chemical assays, this problem might become 
more manageable. The consumer expects a BAS that is safe for consumption. The 
essential quality control and quality assurance procedures that the BAS industry should 





                Figure 1. Quality assurance and control of biologically active supplements  
Fong et al. and Shiltler et al. described that these procedures include acquiring the 
botanicals from collectors who use profitable agriculture and collection practices. To be 
sure that the correct species has been acquired, the material should be authenticated using 
the macroscopic and microscopic botanical examination. Alternative authentication 
assays include genetic identification using PCR techniques, immunoassays to identify 
species-specific proteins or chemical analysis for unique marker compounds. After 
processing, the botanical dietary supplement should be assayed for hazardous 
contaminants such as pesticides, herbicides, heavy metals, mycotoxins, and microbes. 
Besides, pharmaceutical contamination should be ruled out by chromatographic assays 
designed to detect drugs that might have been added either inadvertently or deliberately 
during processing. Finally, the botanical dietary supplement should be standardized 
chemically, based on the concentration of active compoundы, and biologically, based on 
bioassays for known or desired pharmacological and physiological effects. These final 
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standardization steps will ensure the consumer of a reproducible and safe product [23, 
24]. 
2.4. Concerns with biologically active supplement use 
The manufacture’s responsible requirement is to ensure the active biological 
supplements to the consumer that reaches safe, effective, and acceptable. One of the 
important parts for the safety of BASs is the Pre and post-market. 
1) A pre-market phase with a scientific evaluation of the product dossiers, testing of a 
sample, and factory inspections to establish a product specification and to document 
‘Good Manufacturing Practices’ (GMP) compliance of the manufacturing source. 
2) The post-market surveillance is a key part of identifying safety problems associated 
with biologically active supplement products. It is conducted in the distribution chain 
during the surveillance system on it. The market is where products are sold (pharmacies 
and shops), dispensed (hospitals and clinics), or stored (manufacturers, importers, and 
wholesalers). Post-market surveillance is often interpreted as having a system for 
pharmacovigilance to retroactively protect in the future consumers from biologically 
active supplements that are potentially unsafe. Most developing countries adjust the pre-
and –post market system as the main issue. Lack of circulation this system the adverse 
events happened among consumers of BAS. Rudimentary concerns of biologically active 
supplements related to product quality, and safety depend largely on dose. This gives rise 
to health problems. For instance, some dialysis patients receiving substantial doses of 
calcium and the active form of vitamin D on a chronic basis may exceed the Tolerable 
Upper Level (UL) and incur adverse effects on health, including calcification of the soft 
tissues [25].  
Very high doses of vitamin D may also cause adverse effects in people with normal 
kidney function [26]. The most commonly reported reaction-causing supplement is a 
commercially sold weight loss/energy supplement, including symptoms: abdominal or 
chest pain and heart problems. Extracts that are used in bodybuilding and weight loss 
have also been linked to liver injury. This has led to studies of the composition of 
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different supplements. Causes of liver toxicity from supplements appear to be due to 
insufficient regulatory authority, inaccurate product labeling, adulterants, and inconsistent 
sourcing of ingredients [27]. 
This is evidence of causality from BAS recommend to regulators to take action which 
pose a hepatotoxicrisk. 
Timbo B.B. et al. conducted interviews by telephone from the 2002 American 
Health and Diet Survey to analyze the prevalence of adverse events related to supplement 
use. The survey found that 73 %  of US noninstitutionalized adults aged 18 years or older 
and resided in households used a dietary supplement in the previous 12 months, and 4% 
of them had experienced an adverse event that they thought might be related to dietary 
supplement use. 85% of supplement users reported taking supplements (i.e., 
multivitamins plus a singular vitamin/mineral product plus a botanical/herbal product), 
and 13.3% of adverse events reported to multivitamins/multimineral. Those who reported 
an adverse event were asked to list the dietary supplements and their symptoms 
associated with their reaction: abdominal pain, blood pressure problems, nausea, 
vomiting, allergic reactions, dizziness, itching, and rashes. A higher proportion of 
supplement users with adverse events than users without adverse events were 
concurrently taking supplements and prescription drugs or were taking supplements 
instead of prescription drugs to treat or prevent a health condition. 90% of respondents 
discontinued taking the products in question after experiencing an adverse event. Just 
fewer than 50% discussed what they had experienced with a physician, 25% reported 
their event to a health authority, 12% went to the emergency room, and 9% complained to 
the manufacturer or retailer. The 74% of users were taking prescription drugs 
concurrently with DSs.The authors noted that a limitation of the study was that all data 
were self-reported. It is also difficult to definite an adverse effect to a particular 
ingredient within a multiple ingredient products or a particular product, especially when 
multiple supplements are used. The study revealed the lack of knowledge about using 
DSs. It recommended to food and nutrition professional,  and other health care 
18 
 
professionals should take special care to learn about their patients’ use of these products 
[28]. 
Stephen M.S. et al. aimed to evaluate the characteristics of adverse events (AEs) 
reported with dietary supplement use, including dietary supplement type and Medical 
Dictionary for Regulatory Activities (MedDRA) system organ class (SOC) that occurs 
with reported SAEs. A total of 41,121 unique adverse event cases reported to two large, 
U.S.-based dietary supplement marketers in 2.5-years (March 1, 2014-August 31, 2016) 
were assessed for seriousness using established criteria. Each serious adverse event SAE 
was assigned one or more MedDRA preferred terms and system organ classes (SOC). 
The types of supplements most responsible for SAEs were assessed. Of the 41,121 AE 
cases reported, 203 (0.48%) were SAEs. SAEs tended to occur with products marketed 
for weight loss (69.0%) and glycemic control (19.2%). SAEs occurred most commonly in 
the cardiovascular, gastrointestinal, and nervous system disorder SOCs. The percentage 
of SAEs reported to dietary supplement marketers is low, predominantly among 
consumers of two types of supplements. Further study is needed among a larger cohort of 
supplement users to determine causal associations between types of supplement products 
and serious adverse events [29]. 
The main point of BAS products is not contain what is listed on the label. Still, 
others contain more or less than the amount of the herb listed on the label. Moreover, 
many have ingredients that are not listed on the label at all. This problem extends beyond 
the supplement makers and sellers. Some herbal suppliers (those who grow, harvest, or 
sell the crops) may mix or even substitute their crops with less expensive or more readily 
available plants. There is also the problem of accidental contamination when one plant 
grows in with others, as well as cases of mistaken identity (similarity looks between 
plants). Given the global market, all of these problems can make it harder for a company 




In 2013 researchers in Toronto published a report in which they sampled and 
analyzed 44 herbal supplements. The supplements were sold in both the US and Canada, 
and labeled as containing single herbs. Using DNA barcoding analysis, less than half the 
supplements (48%) contained any of the label’s herbs. More than half of the supplements 
contained something that was not on the label (substitutions or fillers). Even among the 
samples that contained the herb on the label, many also contained fillers/contaminants 
[30]. 
Today, a more severe trend in supplements is extra ingredients or contains 
prescription drugs or other compounds that are not listed on their labels. For example, 
some supplement ads are targeted to men as “enhancers” or muscle builders. Certain of 
these so-called “supplements” have been found to contain substances much like Viagra® 
or Cialis® and have been recalled. “Prostate health” supplements have been found to 
contain terazosin, a prescription drug used to treat the symptoms of an enlarged prostate. 
Other ads target women and tout the supplement as an aid to weight loss. Some of these 
“weight loss supplements” contained the weight loss drug “sibutramine,” which was 
banned in the United States and other countries because of the risk of heart attack and 
stroke. The supplement makers recall these only after they have been found to have these 
illegal additives. Then the FDA can seize these drugs and prosecute the companies who 
make them [31]. 
There are also seized that new ingredients with little-known effects are slipped into 
supplements. In one situation, supplements were labeled as being made from geranium 
but contained the stimulant drug dimethylamylamine (DMAA), which is harmful to 
health. This supplement was sold as a “natural stimulant,” but it contained DMAA, a 
human-made drug. The DMAA-containing supplements were exposed after some severe 
events, including several deaths, leading the FDA to send warning letters to US 
manufacturers in 2013.  Such cases can cause serious health issues for people who take 
the supplement. Therefore, monitoring supplement use is essential in countries where 
premarket approval is not required to detect potential adverse reactions. Dietary 
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indicators are known to be imprecise, and estimates of usual intake lack many nutrients 
[32]. Deficiency of biochemical indicators is often not well linked with adverse health 
outcomes that need more attention to be paid to the development of agreed on measures 
of deficiency and excess ingredients (dose). Safety of Biologically active supplements - 
the state of food, indicating the absence of unacceptable risks associated with harmful 
effects on human beings and future generations. 
2.5. Regulation of biologically active supplements in the Kyrgyz Republic  
In the last decade, the BAS market in Kyrgyzstan has shown substantial growth. 
Because they are relatively easy to develop, produce, and register, especially when 
compared to pharmaceuticals. Since 2010 the BAS sales were accomplished via a “black 
market”, but now the government needs to make the BAS market more transparent. More 
progress can be expected to improve the quality control and safety of the BAS products 
and the strict regulation system imposed by the government on the registration process 
and distribution channels. In Kyrgyzstan, in the BAS market are predominantly foreign 
manufactures from 40 countries, such as India, China, Ukraine, the EAEU and EU 
countries, the USA, etc. When the Ministry of Health started registering them as a 
separate group of substances, BAS has been actively promoted on the Kyrgyzstan market. 
Various distribution channels are selling BAS: • Pharmacies; • Specialty stores; • Internet 
websites; direct marketing sales. Even though websites’ market share was quite 
substantial in 2007, now most manufacturers prefer to sell their BAS products via 
pharmacies because consumers trust these stores more than other distribution channels. 
Evidence-based medicine experts and industry analysts predict that the market will 
develop in two directions: increased share of regional sales and social consumer group’s 
involvement. Most pharmaceutical firms are interested in the BAS market since the 
channels of distribution and promotional methods are similar for both BAS and 
pharmaceuticals. Interest in BAS is growing because of the following two factors:  
1. Theoretically, almost all BAS can be advertised. On the contrary, advertising laws on 
pharmaceuticals are stringent, and accordingly, only Over-the-counter (OTC) drugs can 
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be advertised. Despite the enormous potential for BAS promotion, there several 
restrictions imposed for BAS advertising under the Articles 4 and 44 of the Law of the 
Kyrgyz Republic "On Medicines": 
2. The registration procedure most of BAS is relatively simple compared to 
pharmaceuticals. 
Table.2 Comparison special properties between BAS and Pharmaceuticals  
Biological active supplements Pharmaceuticals 
Only toxicology hygiene and studies Compulsory clinical and pre-clinical trials 
Have only recommendations for usage that 
allows flexibility in their promotion 
Designed for curing particular diseases, so 
that the promotion for treatment of other 
illnesses is strictly prohibited 
Can be distributed both in pharmacies and 
other retails stores that have a license 
for selling food products 
Pharmaceuticals can be sold only in 
pharmacies 
Mark-ups for BAS are very high, in some 
regions they can exceed 50% 
Mark-ups for pharmaceuticals  
(29-30%) have a cap in most regions 
According to the law Ministry of Health elaborated decree for BAS regulation: 
1. To the heads of republican, region, city, district health organizations, and the 
Department of Health of Bishkek:  
1.1. To prohibit in health organizations the sale and advertising of BAS                                             
1.2. Prohibit to medical workers carrying out the illegal sale and advertising of BAS 
in healthcare organizations, will take the disciplinary penalty. 
2. Pharmaceutical organizations: 
2.1. Implement (selling) biologically active supplements only in pharmacies 
2.2. To prohibit the implementation of biologically active supplements through the 




In 2017 based on law (Article 4; September 2013) Decree of the Ministry of Health 
of the Kyrgyz Republic dated September 23, 2013, № 549 that biologically active 
supplements are not medicinal products and in 2017 has given authority from Department 
of Drug Provision to the Department of Disease Prevention and State Sanitary and 
Epidemiological Surveillance under the Ministry of Health to regulate biologically active 
supplements as food instead of a type of pharmaceutical drug. Currently, perform all 
regulation procedures of biologically   active supplements under the technical regulation 
document TP TC 021/2011 “On food safety” which is approved between five countries 
under the Eurasian Economic Union. 
The Eurasian Economic Union (EEU) is an international organization of regional 
economic integration with international legal personality and established by the Treaty on 
the Eurasian Economic Union signed by the Heads of States of Belarus, Russia, and  
Kazakhstan in Astana on May 29, 2014. Kyrgyzstan's accession treaty came into effect on 
6 August 2015. The objectives of the adoption of the technical regulations are: 
- Protection of life and human health; 
- Prevention of actions misleading purchasers (consumers); 
- Protection of the environment. 
Before signature to the agreement of EEU: the regulation system of registration and 
certification procedures on BAS approved by the Department of Drug Provision and 
Medical Equipment under the Ministry of Health as a rule of medicine. The establishment 
of the Eurasian Economic Union (EEU) between five countries and later on the Eurasian 
Economic Union (EEU) affected the regulatory regime. Developing the technical 
regulations by these countries must be consistent with each other.                                                                                
Safety requirements for specialized BAS products following the Technical regulation:                                                                                           
►For use in the production (manufacturing) of BAS are not allowed plants and their 
products, objects, animal, bacteria, fungi, and biologically active substances hazardous to 
human life and health and set out in Annex 7 to this technical regulation.  
23 
 
►Biologically active supplements must meet the hygienic requirements of food safety. 
Contents in a daily dose of BAS derived from plants and (or) their extracts should be in 
the range of from 10% to 50% of the value of a single therapeutic dose determined with 
the use of these substances as medicaments [1, 33,34].                                                                                    
2.5.1. Confirmation quality of the biologically active supplement products 
The applicant in the confirmation of food products except state control can register 
by the laws of the State - a member of the Customs Union on its territory a legal entity or 
person. Confirmation of compliance of food products under the requirement of technical 
regulations of the Customs Union held in the form: 
1) Confirmation (declaration) of conformity of food products;  
2) The state registration of a new kind of food;  
3) The state registration of specialized food products; 
4) Veterinary-sanitary inspection.   
The declaration of conformity of food products in the customs territory of the Customs 
Union, with the exception of unprocessed food products of animal origin, specialized 
food products, and vinegar. Biologically active supplements are considered a specialized 
food product; therefore, it is not subject to the declaration of conformity. 
The state registration of food products of a new type is carried out at the stage of 
their manufacturing for the first time in the customs territory of the Customs Union. It is 
imported into the customs territory of the Customs Union approving its conformity by 
appropriate state authority. The validity of the state registration of a new kind of food is 
perpetual. Therefore, such food products are not considered a new type of food product 
and are not subject to state registration of the applicant. During the registration process of 
the new kind of food, in case of a new kind of harm, the process may be terminated or 
suspended, established as a result of state control  member of the EEU. The other state 
registration of the new kind of food follows the state registration of specialized food 
products. The State registration of specialized food products, including BAS,  holds the 
body authorized by the state of the Department of Disease Prevention and State Sanitary 
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and Epidemiological Surveillance under the Ministry of Health of the Kyrgyz Republic.  
In 2016 Ministry of Economic of the Kyrgyz Republic declared a decree for recognition 
of conformity confirmation results/registration of biologically active supplements: 
 - Control for biologically active supplements conducted by the technical regulation of the 
Eurasian Economic Union TR CU 021/2011 “On food safety”; 
 - State registration of biologically active supplements is carried out at the stage of 
manufacturing  and import to customs territory in the EU; 
 - Biological active supplements are allowed to be produced (manufactured), stored, 
transported, and sold after state registration; 
 - All stages of control of confirmation system of BAS held on Department of Disease 
Prevention and State Sanitary and Epidemiological Surveillance of the Kyrgyz Republic; 
 - The state registration of the BAS conducted under the technical regulation document 
TR CU 021/2011 “On food safety” and it came to effect on August 2017 in the territory 
of the Kyrgyz Republic; 
 - Data on the registration of biologically active supplements are entered into the Register 
of State Registration Certificates and is perpetual; 
In Article 53 of the agreement of Eurasian Economic Union about active biological 
supplements are issued on the territory of the EAEU and provided that it has passed the 
necessary conformity assessment procedures established by the technical regulations TR 
CU 021/2011; The applicant has the right to appeal to the decision authority for the 
registration of BAS products in the courts. 
The Kyrgyz Republic ensures the regulation of biologically active supplements that 
comply with the requirements of the technical regulations TR CU 021/2011 on its 
territory without presenting additional requirements for BAS and without conducting 
additional conformity assessment procedures. The Department of Disease Prevention and 
State Sanitary and Epidemiological Surveillance assess of all comply document packages 
for the registration BAS product under the list of technical regulation requirements. For 
instance, the quality of control for BAS should be confirmed by accreditation laboratory 
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in the territory of EEU. According to the requirements the state registration implemented 
recognition conformity by state authority.  If any non-compliance with these technical 
regulations, the state registration may be terminated or suspended of registration 
procedure due to state control or by the decision of the judiciary of the state [1,35]. 
The regulatory framework of BAS in Kyrgyzstan was carried out in separate stages.  All 
stages of the BAS are regulated by the official documentation that sets out the 
requirements for BAS composition, the development of their technological process 
production, registration, storage, transporting, labeling and advertising, handling 
complaints and recall. 
Described at the beginning stage of quality control of testing methods throughout 
analytical laboratory evidence and conformity the condition of general control 
mechanism including declaration procedures under the requirement of EEU. According to 
the specialty of BAS, confirmation procedures used specific TR CU documents, as shown 
in Table 3. 
Table 3.The list of Technical Regulations on BAS  
Technical regulation № Name of documents 
TR CU 005/2011 “On packing safety” 
TR CU 021/2011 Article 24 “About Safety of foods” 
TR CU 022/2011 “Food products and labelling” 
TR CU 024/2011 “Technical Regulations for Oil-containing  products” 
TR CU 027/2012 “On safety of particular types of special foodstuff 
including diet clinical and diet protective nutrition” 
TR CU 029/2012 “Requirements of Safety of Food Additives, Fragrances 
and Technological Additional Products” 
It should also be noted that several new regulatory legal acts for improving quality of 
BAS were prepared and nowadays under the conformation of each five countries. 
Especially in there was the amendment of some regulation articles which was not 
appropriate for some countries. For instance, according to the Technical regulation 
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documents added and changed some articles on the technical regulations of the customs 
union “On food safety” TR CU 021/2011; The Average Daily Essential Food and Energy 
Requirements for Fresh Food Labeling which is related to TR CU 022/2011 “On food 
products and labeling” and TR CU 027/2012 “On safety of particular types of special 
foodstuff including diet clinical and protective diet nutrition.” 
The registration procedure, according to the technical regulation of EEU in the customs 
territory ensures the same three stages:                                                                                                                                                    
1. Analysis of provided documents                                                                                                                         
2. Analysis of tests such as: organoleptic, microbiological; toxicological; radiological, 
containing herbs – tests for pesticides (α-β-γ izomers); mycotoxins, DDT and its 
metabolites; authenticity tests that prove the ingredients listed really contain; in some 
cases – tests on Genetically Modified Ingredients.                                                                                                                   
3. Issuance of Certificate of State Registration 
Important notification for a manufacturer before applying to the process of registration: 
• Not every BAS could be registered in Kyrgyzstan in all registration documents in the 
country of origin. (The list of allowed BAS’s ingredients is in Addendum 7 in the 
Technical Regulation: TR CU 021/2011 “About Safety of foods”).  
• The full list of proposed medical use approved in the country of origin could be 
approved only partially by the Kyrgyzstan registration authorities, for instance, labeling 
assessment under the technical regulation TR CU 022-2011.  
• Each biologically active supplement product should have its certificate of registration. 
State registration requirements are quite complicated in every country of the EEU. 
Therefore necessary to amend some articles in the technical regulation documents by 
requesting of each country.  
The procedure of mandatory registration following is the list of documents which the 
manufacturer or its authorized representative must submit along with an application in 
order to obtain a certificate of state registration: 
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1. Copies of the documents approved by appropriate authorities in the country of 
manufacture also conform that this product is classified as BAS and is not a drug and 
proves its safety for human beings. These copies must be legalized. 
2. Document which is containing a full list of ingredients of the product. BAS is based on 
herbs - their name in Latin and the method of preparation and explanations of those 
ingredients commonly used in foods. 
3. Standards, references, technical regulations, laws, technological instructions, 
specifications, recipes used for the manufacturing process of the product. 
4. Labeling in the Kyrgyz and Russian languages and  a sample of the original label used 
in the country of manufacture. 
5. Usage instructions, annotations in Kyrgyz and Russian languages (not all but necessary 
information could be placed on the label). 
6. Explanation note containing the scientific grounds for BAS compositions; 
recommendation, contraindications for use and duration, doses, and side effects. 
7. Manufacture certificates on toxicological, radiological, hygienic, and biological 
efficiency and other protocols, if requested. 
8. If contained in the BAS live microorganisms, whether need document the type in the 
Latin language, information about the item (passport, certificate or some other 
document). 
9. Confirmation certificate that BAS does or does not contain genetically modified 
components. 
10. Verifying certificate that this BAS does not contain a drug or psychoactive-related 
components or other substances.  
11. In case a trademark exists, a copy of the trademark certificate by legalized properly. 
12. Protocols of tests that are approved by manufacture and trials wherever available. 
13. Documents on sample selection procedure indicating the dates of selection, number of 
the sample, name of the product, manufacture’s address, producing date, and the person 
name who participated in the sample selection process. 
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14. Power of attorney to get the registration certificate. 
15. Brief information on the manufacturing process. 
16. BASs for sportsmen and designed to enlarge the muscles - a document from the 
manufacturer approving that do not contain components attributed to steroids. 
17. Certificates of conformity of active ingredients in the BAS product. 
18. The main document should be properly legalized, confirming that the manufacturing 
process for BAS complies with national and international standards, such as  GMP, ISO 
9000-9002 ect. 
19. Copies of invoices for samples that is permitted to “Entry allowed”. 
20. Usually, samples selected number of 6-8 or 200-300 grams each. 
The number of 2, 6, 8, 9, 13, 15, 16 items should be stamped and signed by the 
manufacturer.  
After the completed the whole process of the registration process, a manufacturer/ 
authorized representative receives the following documents: 
 ►Registration state certificate that is valid perpetual (until some changes occur); 
 ►Expert conclusion of confirmation for safety of the biologically active supplement; 
 ►Conclusions of other laboratories, if during the registration process, extra tests were 
required [34]. 
Regarding the labeling of manufactured products and packaging of BASs, the 
requirements established in the technical regulations of the Customs Union must be 
observed: TR CU 022/2011 “Food products and labeling” - contains the rules for labeling 
food products;  TR CU 005/2011 “On packing safety” - defines the safety requirements 
for various types of packaging materials. 
The state registration for a new kind of food is held at the manufacturing stage for 
the first time in the customs territory of the Customs Union, and food products imported 
into the customs territory of the Customs Union - before its first import into the customs 
territory of the Customs Union. The state registration for a new kind of food is perpetual, 
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and in the future, such food product is not considered a new type of food products and is 
not subject to state registration of the applicant. 
It should be noted that currently, the main barriers to the turnover of biologically active 
supplements in a single economic space are associated with different approaches to 
regulation in different EEU countries and the lack of a single document in part of the 
requirements for biologically active supplements. Lack of harmonization of national 
regulations with the current technical regulations on the critical disagreements in 
interpreting concepts and requirements during the confirmation its compliance and 
labeling and advertising differently in the EEU countries. For instance, one of the 
important procedures on the conformation of the product is "Recognition conformity» for 
biologically active supplements. This document confirms the quality of biologically 
active supplements by the manufacturer itself. Some unscrupulous manufacturers can 
disrupt technology and formulations and put on the market medicines that have not 
passed the proper tests. Such facts of violations are dangerous to public health.  Due to 
more frequent detection of substandard and falsified biologically active supplements, the 
crisis in the regulation of biologically active supplements turnover in Kyrgyzstan should 
be noted. Also, experts of evidence-based medicine regularly identify violations in the 
sphere of BASs circulation. In Kyrgyzstan, not envisaged clinical trials for the 
biologically active supplements. Such issues make an obstacle to the control system of 
the BAS in the country.  
The unified register of specialized food products is an integral part of the Unified 
register of registered food products. It consists of national parts of the unified register of 
specialized food products, the formation and maintenance of which is provided by the 
bodies for registration of specialized food products of the Customs Union member state. 
The primary source of information about the state registration of specialized food 
products is entered in the unified register of specialized food products, which contains a 
list of BAS that have passed state the registration in the Kyrgyz Republic. It is an integral 
part of the Unified register for registering specialized food products of the Customs 
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Union member state. By this registration, BAS products were registered for 2017 - 2020, 
155 names consisted of 95% import BAS products. This is a high indicator that is 
dominated by foreign products instead of domestic BAS products in the pharmaceutical 
market. Also, it is indirectly indicating the demand for the BAS needs of the population. 
To obtain an objective picture of the market for medicinal plants, we studied the 
dynamics of the registration of biological active supplement products of domestic and 
foreign production in the Kyrgyz Republic. The data are presented in Figure 2. As shown 
from this figure, the largest number of biologically active supplements was registered in 
2019. In subsequent years, their registration continues in the different dynamics. Because 
of the reorganizations carried out in the Department of Disease Prevention and State 
Sanitary and Epidemiological Surveillance and for some other reasons, there were 
difficulties with accepting BAS products for the registration procedure [1]. 
 
Figure 2. Dynamic’s registration of the biologically active supplements for 2017-2020. 
Russia adopted a new rule for labeling from 01.01.2019, FZ-488, for the provision of 




















supplements, other food, and non-food products imply that a unique special code is put on 
the package, a unique sequence of symbols. 
The innovation is intended to solve the following urgent problems of technical regulation: 
◦ create an automatic product tracking system; 
◦ protect consumers from counterfeiting; 
◦ fight against unscrupulous companies supplying counterfeit products to the market. 
Because of the new rules, the buyer will obtain the maximum information about the BAS 
by pointing at the unique code of a special scanner installed on a mobile device. It will 
give information about how and when the goods were produced, through what channels 
they entered the distribution network [34, 35]. This model successfully practiced almost 
two years in Russia, contributing to improvement  their control system on BAS.  
2.5.2. Modern aspects of classification of the biologically active supplements 
Nutrition is one of the most critical factors mediating connecting a person with the 
external environment and determining general health status [36]. A new area of 
knowledge - pharmaconutriology - is the border line between nutrition science and 
pharmacology [37]. BASs are one of the main components of a healthy human diet. 
Problems of ecology, unbalanced nutrition, lack of exercise leads to the fact that dietary 
supplement becomes practically necessary and vital in our modern life. 
The classification is carried out based on theoretical normative legal and scientific and 
methodological literature, regulatory documents, publications and information manuals, 
systematization and subsequent logical, structural and comparative analysis.  
Nutritional supplements are needed to give the dosage form specific properties, qualities 
and ensure the safety of the components of the drug. The food supplements related to 
relative emulsifiers, preservatives, flavorings, and other auxiliary substances [38]. 
Classifications of dietary supplements are numerous, the main specific area based on 
biologically active components, physiological action, and functional purpose, methods of 
obtaining, forms, and other signs [36, 37, and 38]. 
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The dynamic development of biologically active supplements of the pharmaceutical 
market and their diversity made difficulties creating of a unified classification, therefore, 
taking valuable parts of it by official normative documents [39]. 
Nutraceuticals are dietary supplements used to correct human food’s chemical 
composition (additional sources of nutrients: protein, amino acids, fats, carbohydrates, 
vitamins, minerals, dietary fiber). The functional role of nutraceuticals is shown in Figure 
3. The ultimate goal of using nutraceuticals is to improve a person’s nutritional status, 
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Table 4. Classification by composition and ingredients of biological active supplements  
Group Contents of biological active supplements 
1 Mainly based on proteins, amino acids and their complexes 
2 Mainly based on animal and vegetable lipids 
3 Based on predominantly digestible carbohydrates, including honey with 
additives of biologically active components, syrups, etc. 
4 Based mainly on dietary fiber (cellulose, mercury pectin, gummi, 
microcrystalline cellulose, bran, fructo-oligosaccharide, chitosan and other 
polysaccharides) 
5 Based on pure substances (vitamins, minerals, organic acids, etc.) or their 
concentrates (plant extracts, etc.) using various excipients, including dry 
beverage concentrates 
6 Based on natural minerals (zeolites, etc.), including mummy 
7 On the base of plants, including flower pollen: dry (teas) and liquid (elixirs, 
balms, tinctures, etc.) 
8 Based on the processing of meat and dairy raw materials, including offal, 
poultry; arthropods, amphibians, beekeeping products (royal jelly, propolis, etc.) 
9 Based on fish, marine invertebrates, crustaceans, mollusks and other seafood, 
plant marine organisms (algae, etc.) 
10 Based on probiotic microorganisms 
Parapharmaceuticals are dietary supplements used for prevention, adjuvant therapy, and 
support within the physiological boundaries of the functional activity of organs and 
systems. These are natural remedies that have a directed physiological effect, and they are 














            Figure 4. The main functional role of BAS- parapharmaceuticals 
Table 5. Classification on the physiological effect on the body of BAS 
№ The name of group 
1 BAS acting on the digestive system 
2 BAS acting on the hematopoietic system 
3 BAS to maintain the functions of the cardiovascular system 
4 BAS used to eliminate various problems with skin and hair 
5 BAS affecting the reproductive system 
6 BAS that affect the function of the endocrine glands 
7 BAS that support the function of the immune system 
8 BAS used for viral, bacterial and fungal diseases 
9 BAS used in diseases of the skeletal system 
10 BAS that affect the functions of the central nervous system 
11 BAS used in diseases of the respiratory system 
Parapharmaceutical’s function 
Regulation within the 
physiological boundaries of the 
functional activity of organs 
and systems 
Adatogenic effect 
Regulation nervous activity 
Regulation of 
microbiogeocenosis of the 
gastrointestinal tract 
Adaptation to extreme conditions 
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12 BAS acting on the sentiments 
13 BAS used for poisoning and intoxication 
14 BAS acting on the urinary system 
15 BAS acting on the body as a whole 
16 BAS for losing weight and  body cleansing  
Table 6. Classification by contents of BAS 
№ The name of groups 
1 Balms, teas, explosions, fees 
2 Proteins, amino acids and their derivatives 
3 Vitamin and mineral complexes 
4 Vitamins, vitamin-like substances and coenzymes 
5 Natural metabolites 
6 Fats, fat-like substances and their derivatives 
7 Macro and micro elements 
8 Polyphenolic compounds 
9 Prebiotics and probiotics 
10 Beekeeping products 
11 Products of plant, animal or mineral origin 
12 Carbohydrates and their processed products 
13 Enzymes of plant or microbial origin 
14 Raw materials for BAS 
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The creation of a unified classification of biologically active supplements will help to the 
regulation system on it. Improving the regulation of BASs turnover is one of the state’s 
top priority tasks in this area of research. 
     2.6. Regulation statement of health/functional food in the Republic of Korea 
 2.6.1. Key term of health/functional food (HFF) 
The term, biologically active supplements, considered in Korea as “health/functional 
foods.” It was defined in the Korean Health/Functional Food Act refers to foods 
manufactured or processed with functional raw materials or ingredients useful for 
modification of physiological functions, maintenance of homeostasis, or improvement of 
specific physiological parameters. The term “functionality” means utilizing nutrients to 
affect the human body’s  physiological functions or providing beneficial effects for 
hygiene purposes, including psychological benefits. Thus, the definition of the functional 
ingredient is a substance providing health benefits and falls under any of the following 
subgroups: elaborated raw material originated from an animal, plant, or microorganism; 
extract or purified substance of any ingredients; synthetic duplicate of the purified 
substance of any ingredient;  or combination of any ingredients which are described 
above.  
The Korean Health and Welfare Committee of the National Assembly proposed the 
HFFA in November 2000. In August 2002, the HFFA was enacted as a new regulatory 
framework for the safety, efficacy, and labeling of HFFs, and it came into effect in 
January 2004.  The Act’s main goal was to enhance public health by ensuring the safety 
of new bioactive ingredients. In 2004, the law defined HFFs as “food supplements such 
as pills, tablets, capsules, powder, and liquids”; in other words, conventional foods were 
not permitted to make any such claims. However, with increasing pressure from the food 
industry, after 2008, the definition of HFF was broadly expanded to encompass all types 
of processed foods. The standardization, safety, and efficacy of a new active ingredient 
are reviewed by the Ministry of Food and Drug Safety to receive approval as a product-
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specific HFF. This authority also makes manufacturers or distributors responsible for 
submitting all evidence to substantiate their products claims. Conforming to international 
standards and protecting public health requires constant upgrading of the 
Health/Functional Food Act [41].  
Now, HFFs are defined as “food manufactured or processed with ingredients or 
components that possess functionality useful for the human body.” However, foods for 
special dietary usage remain under different regulations according to food hygiene laws.                                                                                                         
Relevant laws and regulations which are used for regulation of the HFFs: 
 Food Hygiene Act 
 Health/Functional Foods Act  
 Enforcement Rule of Health/Functional Foods Act 
 Health/Functional Food Code 
 Regulation on Approval of Functional Ingredients for Health/Functional Foods 
 Labeling Standard for Health/Functional Foods 
 Regulations on Recognition of Raw Materials or Ingredients of HFFs 
 Regulations on Imported HFF Notification and Inspection Procedure 
 Prohibited Ingredients for Korea’s Health Functional Food 
2.6.2. Classification of health/functional foods 
Health/functional foods in Korea are divided into two subcategories: generic and 
product-specific. Generic HFFs are defined as products with functional ingredients listed 
by the Ministry of Food and Drug Safety (MFDS). These products include vitamins, 
minerals, and various other functional compounds. All new ingredients that are not 
generic HFFs are subjected to efficacy evaluation before marketing based on their 
ingredients or physiologically active components to ensure the accuracy of the health 
claims. Authorization is granted on a product-by-product basis by issuing a certificate 
without regulatory amendments. The MFDS has the exclusive authority to evaluate the 
safety and efficacy of HFFs before their introduction to the market, and it also keeps 
manufacturers and distributors responsible for providing all evidence regarding the 
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advertised claims of their products by developing a system for substantiation of claims or 
relying on existing information. Under the HFFA, claims regarding nutritive and other 
functions and  reductions in disease risk that are compatible with those adopted by the 
Codex Alimentarius Commission in 2004 [42], can be used for labeling and advertising 
of HFFs. Each claim type is defined as follows:     
•Nutrient-function claims: These claims indicate the nutrient’s physiological role in the 
development, growth and normal functions of the body. Such claims apply to the 
nutrients, which have their own Recommended Daily Allowance (RDA) and must be 
based on the current level of nutrition as a source of evidence. 
• Reduction of disease risk claims: It describes the relationship between the consumption 
of HFFs and the reduced risk of developing a disease or health-related condition. 
• Other function claims: These claims are related to specific beneficial effects of HFFs in 
the context of the total diet on normal functions of the body. Such claims help to positive 
contributions toward health, the specific improvement of a function, or the modification 
or preservation of health. 
2.6.3. Generic health functional foods  
Table 7 indicated that in 2004, the Health/functional Food Act references 37 generic 
HFFs, including 14 vitamins, 11 minerals, essential amino acids, proteins, dietary fiber 
(which is a collective term for non-digestible fiber) available as nutritional supplements 
and as 55 functional ingredients, including ginseng, green tea extracts, and various fibers 
[43]. The MFDS considered these generic HFFs into an HFF code and divided them as 
categories: nutritional supplements, health supplements, and ginseng products. According 
to these categories, the MFDS re-evaluated 37 generic HFFs for scientific substantiation 
of their claims from 2003 to 2007. As a result, several generic HFFs, including royal 
jelly, yeast, bee pollen, digestive enzymes, turtles, and eels, were eliminated from the 
HFF category. These products are re-categorized as conventional food, which is not able 
to bear health claims [44]. 
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Because of several ambiguous expressions in several claims were changed into 
“enhanced function” claims. Dietary fibers were listed separately according to their raw 
materials and were regarded as separate functional ingredients.  
In Korea, it is required that anyone selling HFFs should get government approval. Also, 
to expand the number of generic HFFs covered in the HFF code, new principles for the 
addition of generic HFFs among product-specific HFFs were introduced.  
The functional ingredients estimated by the Regulation on Approval of Functional 
Ingredients for HFF which is permitted to add to the Code according these cases: “if the 
item passed from the date of the manufacturing report or the import report , or three or 
more business persons file the item manufacturing report; or in cases where the person 
who has obtained the recognition under the provision of Article 14 (2) of the Health 
Functional Food Act then the item recognized  as a functional ingredient and requests the 
adding (provided three or more persons obtain the recognition). However, sometimes 
after being recognized as a functional ingredient, the applicant requests data protection 
concerning their manufacturing processes, human studies on functionality, and toxicology 
studies. In these cases, adding the functional ingredient can be postponed for up to 5 
years from the date of the item manufacturing report or import report, dependent upon the 
requested validity. For generic HFFs, nutrient-function claims can only be made for 












Table 7. Generic health functional food in HFF Code 
Nutrients 
Vitamins Minerals 





























Ginseng Red ginseng Plants containing/ 
chlorophyll 
Chlorella/spirulina 
Green tea extracts Aloe whole leaves Propolis extracts Coenzyme Q10 
Soybean isoflavone Omega-3 fatty acids γ-Linoleic acid Lecithin 
Squalene Phytosterol/-ester Alkoxyglycerol Octacosanol 















Milk thistle extract Phosphatidylserine Primroseseed extract Red yeast rice 
Ganoderma 







oligosaccharide    
L-Theanine Soybean protein  






















2.6.4. Product-specific health functional foods 
If manufacturers or distributors want to market HFFs that are not included in the list 
of generic HFFs (and hence is regarded as new), they must apply a product-specific HFF. 
In that case, manufacturers or distributors must provide the MFDS with evidence of the 
standardization, safety, and efficacy of the product [45]. 
The MFDS then performs a pre-market review within 120 days of receiving the 
application, focusing on the origin and nature of the ingredients, the content of functional 
components (or index components), processing methods, information on the methods and 
validation for analysis of functional components, stability data, and purity (in terms of the 
content of microbial, heavy metals, pesticides, etc.), as well as scientific evidence for the 
safety and efficacy of the HFF. 
The evaluation by the MFDS starts once the applicant has submitted the relevant 
documents. The MFDS first determines whether the standardization has been performed 
adequately and then evaluates the safety, efficacy, and specifications.  
Standardization: The manufacturer submits data on the specific characteristics of the 
functional ingredient (such as cases of an unclear functional ingredient or an index 
ingredient for identifying raw materials and states change in the content of functional or 
index component) arising from the primary manufacturing process, and then the MFDS 
evaluates the adequacy of these data.  
Safety evaluation: The safety of the active ingredient is assessed by the MFDS, which is 
responsible for reviewing the submitted data, including detailed descriptions on the 
history of use, manufacturing processes, the quantity for consumption, results of toxicity 
tests, results of human studies, and results of nutritional evaluation and bioavailability. 
The safety of the active ingredient must be validated scientifically according to the 
preparation of safety data by three categories: (1) cannot be used as a raw ingredient for 
an HFF; (2) scientific data or historical use describing its manufacturing process, usage, 
and the amount of intake, database searches of the side effects, toxicity, and evaluating 
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the amount to be consumed; and (3) evaluating the nutritional effects, toxicity data, and 
other data relevant for proof of safety. 
Efficacy evaluation: The evaluation of HFF efficacy is different from the medicines, as 
the target consumers of HFFs are: healthy individuals or individuals in the preliminary 
stage of a disease or borderline condition in an at-risk group. Therefore, efficacy 
requirements are less distinct for HFFs than for drugs marketed to patients with a medical 
condition. Currently, no formula exists for the extent of studies required to substantiate a 
claim regarding HFFs, with the MFDS applying a generalized standard of “competent 
and reliable scientific evidence,” which provides manufacturers and distributors with 
some degree of flexibility in the type of evidence while contributing to the maintenance 
of consumer confidence in HFFs. To evaluate whether the submitted information 
constitutes competent and reliable scientific evidence, each study is reviewed 
independently, considering the total body of evidence. 
Specification: The applicant must also submit samples of the product with 
documentation regarding the analytical method used for analyzing the functional 
component to the MFDS, which validates the selectivity, precision, accuracy, linearity, 
and range of the method. The MFDS then determines the contents of the functional 
component. If the decision is made to approve the product as an HFF, confirms the period 
of conformity and hygiene specifications. 
2.6.5. Registration prosedure 
1) Business License - A locally registered partner with a corresponding business license 
is necessary in order to register a health functional food; this requires that the local entity 
is eligible for a business license, complies with national standards, and notifies its 
intended activities to the local Guide (Article 4-13 Health Functional Food Code). 
2) Declaration - If the applicant wants to import HFF, file a declaration with the MFDS 
(Article 8 Health Functional Food Code). According to the list of the Health Functional 
Food Code, a distinction is made for products containing substances - subject to simple 
notification - and substances that have not been approved which are registration needs. 
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3) Approval of functional ingredients - The approval of new functional ingredients is 
further elaborated upon in the Regulation on Approval of Functional Ingredient for 
Health Functional Food [46]. 
Article 4 of the Regulation requires (i) that the food complies with the Health 
Functional Food Act, and (ii) that the safety and functionality shall be ensured and 
scientifically proven. 
The applicant should complete the provided form together with the following files: 
i. Two copies of the required documentation (including an original copy) 
ii. A CD containing the documentation 
iii. A sample of the product and the standard of function component  
iv. Result of examination issued by a domestic HFF examination of laboratory analysis. 
The documentation part is only in the case of new functional foods/substances; data needs 
to be submitted. Suppose manufacturers or distributors want to market health/functional 
food that are not included in the list of generic health/functional food. In that case, they 
have to apply for approval as a product-specific health/functional food. Before the official 
review, enterprises must submit documents according to Article 12 of the Regulation on 
Approval of Functional Ingredient for HFF lists the following stages [47]:  
i. Executive summary of all submitted documents  
ii. Origin information: developing history, current history of approval, and use in 
domestic or foreign countries, etc. 
iii. Manufacturing methods and related data   
iv. Characteristics of the ingredients: documents to explain the feature and quality of this 
active ingredient  
v. Materials of the active ingredient’s specification, test method, and test result  
vi. Specification, test method, and test result of harmful substances 
vii. Materials to substantiate the safety 
viii. Materials to substantiate its functional efficacy 
ix. Documents related to the intake dosage, intake method, consumption precautions, etc. 
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x. Confirmation data that the ingredients are not identical with or similar to medicine: 
distinguish the product from medicines, etc. 
A detailed description per an aspect of required documentation follows by article 13 of 
the Regulation. The Regulation also establishes the formal requirements that the 
documents are marked with a table of contents, index number, and document number 
according to their sequence per section. In case one of the required documents cannot be 
provided, the reasons should be stated and included in the relevant section. 
An original copy and executive summary shall be submitted together with a Korean 
translation of the documents. The provided documents will be treated confidentially. 
For the  main labeling requirements of the HFFs used Article 17 of the Health Functional 
Food Act.The names of all ingredients and all imported food products are required to be 
labeled with the necessary information in Korean without additional stickers on packages. 
The outcome and timeline of the procedure for the approval of functional ingredients will 
take 120 days from the application. The FDA may however, request additional 
information, in which case a supplementary period will be determined. In case the 
product cannot be approved, or no additional documentation is submitted, the reasons for 
denial will be stated, and the dossier will be returned to the applicant (articles 6-10). 
If approved, the Commissioner of the MFDS will issue a ´Certificate of Functional 
Ingredient for HFF.’ The certificate can provide for exclusive use of the substance for 5 
years.If any modifications need in the Certificate contents may be amended through an 
“Application of Modification on Certificate of Functional Ingredient for HFF.” 
To help develop the healthy functional food industry, on Nov. 6th, 2019, MFDS 
released a guideline introducing a new consultation service to help enterprises expedite 
approval of functional foods. The MFDS maintains advisory committees for HFFs 
comprising 30 experts with nutrition, food science, medicines, and consumer unions. 
These committees comprise six subcommittees that advise the MFDS about regulations, 
acceptable manufacturing practices, importing and exporting, new active ingredients, 





3.1. Study design 
A descriptive cross‑sectional, online questionnaire‑based study was conducted on 
391 participants from August to September 2020 among the population in the Kyrgyz 
Republic within age above 18years old, including healthcare professionals: doctors, 
pharmacists, and nurses. A structured self‑administered questionnaire was formed based 
on adequate use of the biologically active supplement and evaluation of its status. It 
included three parts: 
● Sociodemographic data and health status, with supplement users and non-users 
● Practices of participants concerning the use of vitamins, minerals, herbals, and other 
dietary supplements with detailed information about the type, form consumption 
frequency, and duration 
● Safety, quality, availability, accessibility, effectiveness, benefits, side effects, existing 
regulatory system in the country 
● Labeling, packing, composition and finally knowledge and opinion regarding 
biologically active supplements in all participants. The independent variables knowledge 
of BASs and gender were compared with the dependent variable of users and non-users. 
Logistic regression was used to reveal BAS use with occupation, income, education, and 
government regulation on BASs. 
Then this research has analyzed a comparative study based on regulation system on 
BAS between the studied countries Kyrgyzstan and Republic of Korea. 
3.2. Study site  
This is a study carried out in Kyrgyzstan among healthcare workers from the 
Infection disease Department of International School of Medicine in Bishkek; National 
Center for Infection Control; Family Hospital №7; Department of Drug Provision and 
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Medical equipment; Department of Disease Prevention and State Sanitary and 
Epidemiological Surveillance; and including pharmacists.  
Population: mostly in Bishkek (capital) and from other cities, regions, and villages. 
Bishkek is the most populated city in Kyrgyzstan (1,012,500 population est.2019) and is 
situated in the north part of Kyrgyzstan. The city’s territory is 169.6 square kilometers 
and is administered separately and not part of any region. There are predominantly 
Kyrgyz residents around 66% while European people make up less than 20% of the 
population and other international populations.  
3.3. Study participants and sampling 
The target populations were users and non-users of the biologically active 
supplements among government employees, private entrepreneurs, doctors, nurses, 
pharmacists, pensioners, and non-employers within age above 18 years old in the Kyrgyz 
Republic. To determine the sample size, used the Cochran equation calculating sample 
for proportions of large populations:  
n=p(1-p)(Z/E)2                                                                                                                 
In the formula n is the sample size, Z2 is the abscissa of the normal curve that cuts off an 
area α at the tails   (1 - α equals the desired 95% confidence level (Z=1.96), E is the 
desired ±5% level of precision (E=0.05), p is the  estimated proportion in the study 
population and q is 1- p(p=0.05), a sample of size 385 was needed:     
 




The sample randomly selected 391 participants by sending a “link” questionaries’ form to 
the respondent’s telephone number. Trained interviewers collected data during August and 
September months in 2020 in all study areas. Among the 391 selected respondents, 372 
responded to the adjusted survey to accommodate an expected 95% response rate. 
3.4. Study variables 
Respondents were asked about taking the BAS in the present. Biologically active 
supplement was defined as a product consumed in tablets, syrup, ointment, powder, herbal 
preparations, gel, ointment, liquid forms, or capsules etc. intended to supplement the diet to 
maintain health.  
Typical examples would be vitamins, minerals, herbs, Energizers (activators), Proteins, 
Vitamins, Minerals, Sport drink, Phytopreparations. The motivation of the population 
regarding use of   BAS products for different reasons such as toning the body, improving 
muscle mass and sports performance, improving brain performance, losing weight, keeping 
weight, striving for longevity and beauty, and preventing disease, self-medication of a 
previously diagnosed disease. 
Independent study variables were categorized into sociodemographic status, 
socioeconomic status, health status, and  BAS fundamental knowledge. Education, income, 
and occupation were used to determine socioeconomic status. Educational background was 
classified into three categories:  primary education, specialized  secondary graduate, and 
high graduate education. The definition for each category is education university degree or  
higher, respectively. Income was also classified into three levels: low, middle, and high.  
Definition for each level is lower-income quartile, second and third income quartile,  
and upper-income quartile, respectively. The occupation was labeled either as a group: the  
first group involved government employers and private entrepreneurs; in the second  
group health professionals: doctors, nurses, pharmacists, and third group considered as no 
occupation involved any jobs,  housemakers, and pensioners unemployed.  




score from one to three, where three was healthy and two wasnormal and their score was 
considered as unhealthy.  
Other variables of the socio-demographic characteristics as covariates included age, 
gender, and geographical location. Geographical location was determined as a group: urban 
and rural residents. Adult, defined between ages 19-29, were grouped into as young adults, 
and between ages 30-59 were considered working adults, and aged over 60 were 
considered elderly, respectively.  
Last part of the survey described independent/dependent variables related to basic 
information about BAS including information sources, purchase location, and side effects; 
taking a course of BAS; difference BAS from medicines;  attitude, and knowledge towards 
biologically active supplement use: safety, quality, effectiveness, accessibility, availability, 
affordability, and regulation of BAS and assessment of network system on BAS in the 
Kyrgyz Republic. Definition of each independent/dependent variables represented in 
Appendix 1. The primary consumption on the practical-theory of BASs according to the 












              Figure 6. Structure model on the basis of questionnaire/survey on BAS 
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Regulation system and quality control of BAS 
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Based on this model developed three hypotheses of the study to answer the research 
question under the variables: first by gender; the second through knowledge among 
consumer and non-consumer as a dependent variable, and third is identifying association 
government regulation use of BAS in the Kyrgyz Republic. Each hypothesis elucidated the 
research question. 
3.5. Data collection 
In achieving the objectives of the research, a qualitative approach has been used as a 
general research method. To answer the research questions, the data collected from both 
primary and secondary sources were used in the statistical analysis of the BAS use among 
population in the Kyrgyz Republic and the textual analysis of the regulation system 
between two countries Kyrgyz Republic and Republic of Korea. 
The primary study’s main focus was the use of biologically active supplements and 
assessed knowledge on the basic terms of biologically active supplements among the study 
population and the function of the government on the regulation of BASs products. 
The study’s primary data was used a cross-sectional online survey design to gather 
information regarding BAS use, attitudes, and regulation system among the population of 
the Kyrgyz Republic. The survey was administered by interviewing participants 
anonymously in person using a structured questionnaire between August and September of 
this year. The questionnaire was prepared in English, translated into Kyrgyz and Russian 
languages, and back- translated into English to check for consistency. It was pretested on   
7 people in Government Family hospital №7, Naryn province in Kochkor region. The 
questionnaire structure was in four parts, according the dependent and independent 
variables: First, the interviews described the purpose of the study and confidentiality of 
their answers and asked respondents whether they consented to participate. The second part 
was a sociodemographic and socioeconomic profile of the respondent: gender, age, 
geographical location, educational level, occupation, and income. The third part was 
described consumption patterns: use of vitamins, minerals, food supplements, herbal 
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products; composition and form of BAS;  reliable information source and purchase places, 
side effects; duration use of BAS; difference BAS from medicines;  attitude, and 
knowledge towards BAS use: safety, quality, effective, accessibility, availability, 
affordability and part 4 was about regulation of BAS and the respondent assess to network 
system on BAS in the Kyrgyz Republic. 
At the end of the questionnaire form respondents, indicated their suggestion for 
improvement of the biologically active supplement sector in the Kyrgyz Republic. 
In secondary data of  this research has used the documents based on regulation 
procedures of the BAS as a comparative study between the studied countries Kyrgyz 
Republic, Department of Disease Prevention and State Sanitary and Epidemiological 
Surveillance and Republic of Korea, Ministry of Drug and Safety Food. Interwieved 
employees from the Department of Disease Prevention and State Sanitary and 
Epidemiological Surveillance of the Kyrgyz Republic and the necessary information from 
official websites of state bodies of the Kyrgyz Republic and Republic of Korea were also 
used as secondary data. The purpose of this comparative study improve the regulation 
system in Kyrgyzstan compared to the Republic of Korea. 
3.6. Inclusion and exclusion criteria 
The data of this study included 391 respondents aged over 18. Aged under 18 did not 
answer questions relevant to adults, such as fundamental assessment of biologically active 
supplements. Those who did not provide an answer or answered as unknown to a specific 
question on biologically active supplement were excluded from the study. Moreover, those 
with missing responses in other variables were also excluded. In the end, there were 372 

















                       
 
                                Figure 7. Inclusion and exclusion criteria of the study 
3.7. Statistical method 
The results of the respondent’s data were analyzed and performed with the statistical 
method (package SPSS, version 25.0). Using a two-tailered test, p values < 0.05 were 
statistically significant. Described the sociodemographic characteristics by categorical 
variables except for age and income as a continuous variable. For comparison, the means of 
two independent groups were used two-sample t-test to determine the statistical evidence 
that is significantly difference in population means. Concerning categorical variables, the 
frequencies and proportions were calculated by Cross tabulation. Pearson chi-squared 
analyses were used to compare the social characteristics, practice, knowledge, and attitudes 
difference between consumer and non-consumer groups in the study population. Logistic 
regression analyses were performed to determine the association of each sociodemographic 
variable, including age, gender, income, geographical location, health status, with the 
prevalence of BAS use among the study population. The odds ratio (OR) with 95% 
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result. Thus, logistic regression was used as a dependent variable as binary, 1=biologically 
active supplement consumer and 2=biologically active supplement non-consumer, where 𝜒 




)= 𝛽0 + 𝛽1𝜒1 + 𝛽2𝜒2 + 𝛽3𝜒3 + 𝛽3𝜒3 + 𝛽4𝜒4 + 𝛽5𝜒5 + 𝛽6𝜒6 + 𝛽7𝜒7 + 𝛽8𝜒8 + 𝛽9𝜒9 
+ 𝛽10𝜒10 + 𝛽11𝜒11                                                                                                            
𝑦 = BAS consumer=1; BAS non-consumer=2,    
𝜒1 = Education (secondary, high graduate)  
𝜒2 = Income (low, high) 
𝜒3 = Occupation (Unemployed, employed) 
𝜒4 = Health status (Unhealthy, healthy)  
𝜒5 = Age (young adult, elderly)  
𝜒6 = Gender (male, female) 
𝜒7 = Government regulation (yes, no) 
𝜒8 = Knowledge on BAS (yes, no) 
𝜒9 = Safety (yes, no) 
𝜒10=Effectiveness (yes, no)  
𝜒11 =Availability (yes, no) 
                                  Figure 8. Logistic regression model 
The model revealed the third hypothesis, which was identifying association government  
regulation use of BAS. For performing statistical method, the variables: education,  
income, occupation, health status, age were recoded as a binary like others: gender,  
government, knowledge, safety, effectiveness, and availability. Thus, conducted a bivariant  








4.1. Discriptive statistics 
Description sociodemographic characteristics of the study on biologically active 
supplement use among the population in the Kyrgyz Republic present in table 8. It is 
shown percentages of the variables as the weighted frequency with statistical significance 
at 5%. This study population involved 268 (72%) BAS consumers and 104 (28%)  
non-consumers. Mainly proportion of consumers taking BAS products like a course in a 
year (53.7%) compare to less population taking more one course in a year (35.4%), and 
fewer of the proportion sometimes use due to their income. The population geographical 
location mainly proportion 78.7% of urban residents in the consumer group and only 
21.3% amount of portion in rural residents in non-consumer group.  Most consumers were 
female 75.0% (male 25.0%) compare than non-consumer group female 56.7%. Among 
consumers the majority age was medium between 30-59 years, 81.8% and the young age 
19-29 was 8.6%, and elderly above 60 years was 9.7%. Moreover, in the non-consumer 
group, there is less aged group than in the consumer group (5.8% and 9.7%, respectively). 
However, they are significantly more in the consumer group medium-aged population 
81.8% than the non-consumer 71.2%. While consumers: 51.5% had high education, 42.9% 
college graduate education, and 5.6% primary/secondary school graduate education. More 
than half of the consumers were in middle-income class (55.2%) compare other between 
low and high classes (35.1% and 9.7%, respectively) were allocated not equally. While 
65.4% of non-consumers were from the middle-income population.  
Almost similar frequencies were consumers: government employers and private 
entrepreneurs 22.5% and 23.4%, respectively, while health professionals were 31.7% (14% 
doctors, 12.9% pharmacists, and 4.8% nurses) and the unemployed population were 22.4%. 
Primarily in both groups had a permanent job presented as 59.6% in non-consumer group 
and 45.9% in the consumer group.   
54 
 
As described in the previous part, the statistically significant difference between consumer 
and non-consumer groups for all independent study variables was p value=0.05. The 
consumer groups had more people with higher education, higher income, and were 
government employers and private entrepreneurs. Almost half of the consumers appraised 
themselves as relatively usual 47.0%, while 36.2% viewed themselves as healthy and 
16.8% perceived unhealthy. According to this statement: two-fold less healthy and two 
times unhealthier population in consumer groups than non-consumer groups. For instance, 
non-consumer group, 63.5% had the healthy population, and only 7.7% had an unhealthy, 
while in the consumer group, 16.8% had the unhealthy population and 36.2% had a healthy 
population.  
Attitude towards BAS in the consumer group’s population was relatively 79.1% in positive 
opinion and 62.5% population in the non-consumer group in an unfavorable position for 
using BAS. Regarding distinguish of BASs from medicines in consumer group, 90.3% 
population can differentiate, according to this statement, 45.5% of consumers using BAS 
parallel with medicines. Relatively 55.8% of the non-consumer group cannot determine 
BAS difference from medicines; therefore, 78.8% of the population in that group indicated 
no parallel use.  
During the taking of BAS, the central part of the consumers group was taking effect. To 
avoid harmful effects, the BAS products must meet the hygienic requirements of food 
safety.  According to this term included safety of BAS products in this study. 67.2% of the 
consumer group indicated the safety of their taking BAS products; however, were 
happened 20.9% of adverse events in this group during the taking BAS products and 52.8% 
of them individually took action with their harmful effects, and 12.7% of the affected 
population helped by healthcare workers. Also, 74.0% of the non-consumer groups any 
idea about the safety of BAS products. Such as cases government should ensure control of 
quality and safety of BAS products for public health. Therefore, this measure was used to 
assess awareness of the country’s government regulation system among the study 
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population. Half of the non-consumer and consumer groups were no information about 
regulation on BAS products (50.0% and 41.0%). Almost the study population in both 
groups demanded a control system for the BAS sector in the Kyrgyz Republic. The 
proportion of the assessment network system in Kyrgyzstan, which scored from 0 to 10 
was the medium in both groups, presented as a 5-7 level.  
Due to mostly BAS products imported from other countries in Kyrgyzstan, their price was 
more expensive than domestic. Consequently, affordability the primary function play for 
using BAS products and, it’s directly related to the population’s income of the. For 
instance, in both groups, showed more than half the population was in low-income: 
affordability (82.7% of non-consumer and 57.9% consumer). A small number of 
percentages showed both groups as high-income affordability (1.0% and 6.0%). 
Substantially part of consumers had benefited from taking BAS products (89.6%), and 
50.0% of the proportion in the non-consumer groups did not notice the beneficence taking 
of BAS products. Mainly proportions of consumer groups were satisfied for their taking of 
BAS products (81.3%) and generally 60.6% in the non-consumer group indicated 
dissatisfaction for the BAS products. 
Table 8 showed no significant difference regarding education, geographical location,  
income, and side-effects among consumer and non-consumer groups with different 
characteristics (p value=0.275, 0.705, 0.169 and 0.275). The other variables indicated 
statistically significant there was enough evidence to reject the null hypothesis and 
significant evidence to support the alternative hypothesis of each variable on BAS among 








Table 8. Overall characteristics of study population among user and non-user groups 
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Table 8 (continued)  



















































































































































































4.2. Use of biologically active supplement by gender 
In Table 9 shown the widespread use of BAS products between females and males and 
the allocation among them quite different. Female consumers more (77.3%) than males 
(59.8%) while male non-consumers were 40.2%. An independent samples t-test was 
conducted to examine the gender difference in the use of BAS products.  Levene’s Test for 
Equality variances showed no violations, p=0.001. Results indicate that males (M=1.40, 
SD=0.492) used more than females (M=1.23, SD=0.420) ranks on BAS products, 
t(370)=3.49, p< .001, Cohen’s D=0.37. According to this result, we can conclude that BAS 
use in males was significantly higher than in females. Therefore, hypothesis 1 was rejected 
and accepted alternative hypothesis that males and females will differ in the use of 
biologically active supplement products.  
Table 10 illustrates for females and Table 11 for males. The total number 260 were female, 
and 112 were male. Evenly distributed consumer and non-consumer in female  
groups (77.3%, 22.7% respectively) while consisting of male consumers were (59.8%). The 
main parts of both group’s consumer’s ages were similar from 30-59 (80.7% female and 
male 85.0%), consumers female and male groups were in middle income (47.3% and 
79.1%) and by geographical location substantially consumers in both groups from urban 
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residents. Female group consumers mostly had college and high level of education (48.8%, 
44.3%) while non-consumers were more highly educated people (50.8%). Mostly part of 
female consumers had jobs in government/private 49.8%, and male group consumers were 
HCWs 56.7%, while non-consumers of the male had a job in government/private (62.2%). 
The majority in both: female and male groups had normal subjective health status (45.8%, 
50.7%). The majority of male group consumers were familiar with government regulation 
on the BAS (53.7%) than female group consumers (36.8%), while numerous consumers in 
the female group (62.3%) and non-consumers in the male group (86.6%) did not know 
about this subject. Substantially part of consumers in the female groups have checked 
packaging, labeling, and content of BAS before purchasing (82.1%). In reverse, consumers 
in the male groups have not checked the BAS package before buying it (70.6%).  This is a 
common prevalence issue is checking the package, label, and content of BAS products 
before purchasing or using it. It should comply with labeling health claims.  
BAS products  are safe to use because they come from “natural sources” however, in fact, 
it is  different. For instance, BAS products for 66.2% of consumers in the female group 
were safe while 84.4% of non-consumers in males were unsafe or doubt say that was safe. 
Furthermore, mostly non-consumers in both groups did not notice that it was safe. 
Significantly, consumers in the female group (91.5%) were effective while consumers in 
the male group (66.1%) didn’t have effective from BAS products. Even substantially part 
in both groups consumers, combines used with medicines. Distinguish BAS from 
medicines in both group consumers can differentiate (82.0%F, 85.1%M); however the non-
consumers in the male group did not know the difference of BAS from medicines (53.4%). 
Attitude to BAS majority of both groups’ consumers was positive while half of non-
consumers in the male group were negative. Significantly satisfied in female and male 
groups consumers (82%, 49.3%) while male group non-consumers not satisfied (75.6%). 
Notwithstanding the satisfaction in both group consumers, they got adverse events during 
the taking of BAS products (15.4% F, 37.3% M). 
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Accordingly in non-consumers of female and male groups had side-effects before (92.9%, 
73.3%).  Regarding the income, education, geographical location, occupation, packing of 
BAS, and side-effects from taking BAS,  there was no statistically significant difference by 
a female between the two groups: consumer and non-consumer (p value=0.118, 0.232, 
0.662, 0.106, 0.065 and 0.110, respectively), as mentioned in table 10. 
Regarding income, geographical location, education, and side-effects, there were no 
statistically significant differences by a male between consumer and non-consumer groups 
(p value=0.233, 0.656, 0.709, and 0.240, respectively), as shown in table 11. 
Table 9. Biologically active supplement among consumers and non-consumers by gender 
Item 
Use of BAS 
Mean  SD  
P-
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Table 11. Biological active supplement use among male 
  Consumer Non-consumer 
P-
value 
Item  n=67 (59.8%) 
n                % 
n=45  (40.2%) 
    n                % 
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Table 11. (Continued) 

















































4.3. Knowledge, Attitudes towards BAS among consumers and non-consumers 
Table 12 described the difference in knowledge of biologically active supplements 
among  consumer and non-consumer groups. The first line of the table indicated that overall 
knowledge of consumer and non-consumer groups responded to overall knowledge questions 
with statistically significant differences between the two groups: consumers and non-
consumer. In table 12 the result shown that an equal variances t-test applied to reveal a 
statistically reliable difference between the mean number of consumer group (M = 1.42, 
SD=0.815) and non-consumer group (M = 2.36, SD=0.880), t(370) = 9.74, p = 0.001, α = 
0.05. Since p < .001 is less than our chosen significance level α = 0.05, we reject the second 
null hypothesis, thus accepted the alternative hypothesis that there was a significant 
difference in knowledge of BAS among consumers and non-consumers group. Accordingly, 
when looked knowledge questions in the detail, among questions the other response: 
“Importance government control for BAS products” was shown the different meaning that 
there was no significant difference between two statements: that the p=0.944 are greater than 
0.05, that means no significant difference in importance of government control for BAS 
products among consumers and non-consumers. The other statements were statistically 
significant, that means it was difference in knowledge of BAS among consumer and 
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nonconsumer groups regarding to variables: Distinguish BAS products from medicines 
(p=0.001); Benefits after taking BAS products (p=0.001); Combine use of BAS products 
with medicines (p=0.001); Effectiveness (p=0.001); Safety (p=0.001); Comply labeling 
health claims (p=0.01); The government regulation on BAS and Consumer satisfaction 
(p=0.001). 
Table 12. Assessment of BAS knowledge in consumer and non-consumer groups  
Subject BAS users and 
non-users 




Overall knowledge on BAS Yes              268  1.42 0.815 
  0.001* 
No               104  2.36 0.880 
Detailed knowledge on BAS: 
Whether to distinguish BAS 
products from medicines 
Yes 268 1.17 0.541 
0.001* 
No 104 1.72 0.875 
It has benefit after taking BAS 
products 
Yes 268 1.25 0.661 
0.001* 
No 104 2.16 0.904 
BAS products can be  
dangerous when combined  
with prescription medicines  
 
Yes 268 1.74 0.767 
0.001* No 104 2.06 0.459 
Taking BAS products 
effective for health 
Yes 268 1.18 0.559   0.001* 
 No 104 2.35 0.798 
BAS products are safe to use  Yes 268 1.50 0.772   0.001* 
 No 104 2.57 0.773 
BAS products should comply 
labeling health claims 
Yes 268 1.31 0.691 
0.010* 
No 104 1.53 0.800 
The government regulates 
 the quality of BAS  
 
Yes 268 1.79 0.752 
0.001* 
No 104 2.19 0.684 
Importance government 
control for BAS products 
Yes 268 1.16 0.368 
  0.944 
No 104 1.16 0.372 
Whether the quality of BAS 
is sufficient to make 
consumer satisfaction 
Yes 268 1.19 0.390 





4.4. The primary concept attitude towards BAS among the study population 
One the BAS products critical property was its form, knowledge awareness the term of 
biologically active supplements among population, and motivation to consume. During the 
research, the study population measured the BAS products structure knowledge awareness 
on BAS among the population, composition, and motivating factors to consume BAS. 
Knowledge awareness the term of BASs as described in the previous part that the term is 
kind of food supplement used according to the chemical, biological and natural contains 
three categories. A result of the study shown that in the study population majority of people 
understood the term BAS products as a food supplement - 43.5%, vitamin complex - 41.4%, 
and as vitamins-9.4%.  A few people considered as a kind of medicine and usual chemistry. 
Most parts of the population prefer the composition of the BAS as vitamin and minerals 
(48.4%), proteins (23.7%), energizers (18.8%), and a small amount of the population choose 
as herbal and phytopreparations. Based on a study of BAS’s assortment of the population 
used or preferred in the form of capsules, tablets, syrup etc. For instance, the largest number 
of BAS products was presented in capsules, whose percentage is 42.7%. Tables presented 
slightly smaller portions - 18.5%, the herbal preparations, and syrup - 14.2%, 13.2%, 
respectively, as in figure 9 shown kind of forms and motivation factors in percentage. 























Motivation to consume, %
67 
 
Figure 9 shows the distribution of the motivating factors on consuming the BAS products 
among the study population. People were used the BAS in different motivating factors. For 
instance, most of the population (67.7%) used as toning the body and 9.1% to prevent of 
diseases, striving for longevity and beauty. Other factors for improving brain performance 
(5.4%), losing weight (2.4%), improving muscle mass (1.9%), and self-medication of a 
previously diagnosed disease (0.8%).  
Health professionals and experts on medicines maintain that most of the population freely 
chooses the motivation statements without doctor consultation. In Kyrgyzstan, almost 90% 
of the BAS products are imported. For that reason, 72.8% of the study population chooses 
imported BAS products. On the other hand, domestic products have a few BAS products 
assortments compared to imported products.   
4.5. Importance of information sources on the biologically active supplement 
In table 13 show the primary information sources which were essential to use in the 
study population. 40.3% of the study population purchased the BAS products in pharmacy, 
and 21.5% throughout distributors, 18% in particular stores on BAS products and mostly 
urban residents obtained via online internet shop. At the moment of purchase, the main 
crucial component is checking the BAS products packing, labeling, and content. Some BAS 
products do not match labeling, packaging, and contents. As a consequence of this scrutiny 
that mostly the population checked the package before purchasing. The other source of 
purchase is choosing by factors; for instance, 43% of the population preferred by the brand 
of BAS products, 36.6% - by the country of origin, 12.1% by prices, and 5.1% by the quality 
of the BAS. BAS products primary importance is an information source that should be 
reliable and effective for the population. Moreover, the population openly chooses whatever 
sources they want. This scrutiny revealed that 52.2% of the study population appreciated the 
doctors’ advice and 20.4% specified that they have followed the family, friend’s 




Table 13. Information sources of biologically active supplement in the population  
Independent variables  Frequency Percent 
Purchase place Pharmacy 150 40.3 
Special store 67 18.0 
Healthy food store 19 5.1 
Online store 43 11.6 
Fitness club 3 0.8 
Distributors 80 21.5 
Total 362 97.3 
Important factor for 
purchase  
Brand 160 43.0 
Price 45 12.1 
Country of origin 136 36.6 
Advertising 12 3.2 
Quality 19 5.1 
Total 372 100.0 
Information source Doctor recommendation 194 52.2 
Family recommendation 22 5.9 
Friends recommendation 76 20.4 
Positive feedback on the 
internet 
52 14.0 
Advertising on TV/Inter 14 3.8 
Advertising on public place 5 1.3 
Fitness trainer recom. 4 1.1 
Cosmetologist recom 3 0.8 





4.6. Biologically active supplement usage patterns among the study population  
Odd ration (OR) with 95% Confidence interval (CI) measured according to the 
variables: education, health status, government regulation, the safety of taking BAS, 
availability, effectiveness, attitude to BAS and in the results showed association BAS 
consumption with these variables are presented in Table 14. Results showed that BAS use 
different from on sociodemographic of the study population. For instance age (OR 0.602, 
95% CI 0.485 to 0.747) and occupation (OR 0.527, 95% CI 0.312 to 0.891) was associated 
lower rate of BAS use and statistically significant (p value=0.001 and 0.017, respectively). 
Income (OR 0.763, 95% CI 0.385 to 1.510), gender (OR 0.706, 95% CI 0.351 to 1.422) both 
these groups were associated lower rate of BAS use and not statistically significant. Between 
Education (OR 1.291, 95% CI 0.694 to 2.401), Availability (OR 1.078, 95% CI 0.711 to 
1.634) and Government regulation (OR 1.190, 95% CI 0.731-1.936), there was a trend for 
higher BAS use and strong association use of BAS with education, availability to BAS 
products and government regulation on BAS. On the other hand, no statistically significant 
differences between these variables regards the use of BAS, as shown in Table 14  
(p value=0.419, 0.725, 0.484, respectively). 
People with health status (OR 1.686, 95% CI 1.019 to 2.791), Safety of BAS products (OR 
1.661, 95% CI 1.078 to 2.559), and Attitude to BAS (OR 1.862, 95% CI 1.264 to 2.744) 
were also more likely to consume BAS and strong associated with use of BAS. There was 
statistically significant (p value=0.042, 0.021 and 0.002. Effectiveness was also associated 










  Table 14. Logistic regression for usage of BAS in specific variables 
Variables OR 95%CI    P-Value 
 Age  0.602 0.485-0.747      0.001* 
Education 1.291 0.694-2.401      0.419 
Income 0.763 0.385-1.510      0.437 
Occupation 0.527 0.312-0.891      0.017* 
Health status 1.686 1.019-2.791      0.042* 
Gender  0.706 0.351-1.422      0.330 
Government regulation 1.190 0.731-1.936      0.484 
Safety 1.661 1.078-2.559      0.021* 
Effectivness 4.146 2.711-6.342      0.001* 
Availability 1.078 0.711-1.634      0.725 
Attitude to BAS 1.862 1.264-2.744      0.002* 
 *-Statistically significant 
4.7. Comparative study on regulations of biologically active supplement (BAS) in 
Kyrgyzstan and health functional food (HFF) in Republic of Korea 
       The BAS regulations in Kyrgyzstan and HFF in Republic of Korea have a difference 
according to their functionality and law on food safety in each country. This is research 
reveals distinguish of the BAS and HFF between the two countries. The use of these 
product’s functionality among two population is similar, the difference of their regulation 
system. The research study concludes that in Korea, the regulation on HFF well-adjusted 
regulation system than Kyrgyzstan. Compare to Korea the BAS sector in Kyrgyzstan is one 
of the emerging industries. Significantly, for the last 10 years is drastically growing, the BAS 
market in Kyrgyzstan through the networking market system. Regarding this market 
respectively requests regulation on it. Therefore in Kyrgyzstan BAS sector demand enact 
appropriate to act on its regulation system from experienced countries profile such as the 
Korea. In table 15 indicated the differences in the BAS and HFF on specific characteristics 
between two countries. 
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Table 15. Difference of regulation on BAS in Kyrgyzstan and HFF in Republic of Korea 
       Kyrgyzstan        Republic of Korea 
1. Term: Biologically active supplement  1. Term: Health Functional Food    
2. Decree of the Ministry of Health of the 
Kyrgyz Republic dated September 23, 2013 
№ 549 that BAS are not medicinal products 
and it came into effect regulation on it in 
2017 by given authority to DPSSES  
2. In August 2002, the HFFA was enacted 
as a new regulatory framework for the 
safety, efficacy, and labeling of HFFs, and 
it came into effect in January 2004. 
Currently regulated by MFDS   
3. The objectives of the adoption of the TR: 
•  Protection of human health;  
• Prevention  of actions misleading 
consumers; 
• Protection of the environment 
3. The ultimate goal of the Act was to 
enhance public health by ensuring the 
safety of new bioactive ingredients 
4. 1) Confirmation (declaration) of 
conformity of food products;  
 2) The state registration of a new kind of 
food;   
3) The state registration of specialized food 
products (included BAS); 
4) Veterinary-sanitary inspection   
4. Health/functional foods in Korea divided 
into two subcategories: generic and 
product-specific. Generic HFFs are defined 
as products having functional ingredients as 
listed by the MFDS. If are not included in 
the list of generic HFFs, they must lodge an 
application for a product-specific HFF 
5. Not every BAS could be registered in 
Kyrgyzstan in cases of all registration 
documents in the country of origin 
5. Every HFF should check it quality 
according the MFDS with evidence of the 
standardization, safety, and efficacy  
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       Kyrgyzstan        Republic of Korea 
6. The new type of BAS is carried out at the 
stage of their manufacturing for the first 
time in the customs territory, and conform 
by appropriate state authority 
6. The functional ingredients recognized 
under the Regulation on Approval of 
Functional Ingredients for HFF were 
permitted to be added to the Code 
7. Pre-market checks on analysis of provided 
documents: Analysis of tests such as: 
organoleptic, microbiological; toxicological; 
radiological, containing herbs – tests for 
pesticides (α-β-γ izomers); micotoxins, in 
some cases – tests on Generally Modified 
Ingredients                                                                                                                                                                                                                     
7. Pre-market focusing on the origin and 
nature of the ingredients, content of 
functional components, methods, validation 
methods for analysis, stability data, and 
purity (microbial, heavy metals, pesticides, 
etc.), scientific evidence for the safety and 
efficacy
8. BAS registration comply with the 
requirements of the TR CU 021/2011 on its 
territory without presenting additional 
requirements for BAS and without 
conducting additional conformity 
8. Registration of HFF followed: 
1) Business License  
2) Declaration with the MFDS 
3) Approvement ingredients 
9. The DPSSES has limited authority to 
evaluate safety and efficacy of the BAS 
products, also regulating  manufacturers and 
distributers products  
9. The MFDS the exclusive authority to 
evaluate the safety and efficacy of HFFs 
prior to their introduction of the market, 
and it also keeps manufacturers and 
distributors responsible for their products 
10. Valid of registration certificate is 
perpetual 








The study's primary purpose was to scrutinize the selected consumer and non-consumer 
population attitudes towards biologically active supplements: safety, quality, availability, 
effectiveness, and knowledge. According to the results of the study, the hypothesis indicated: 
1) Null hypothesis was rejected and accepted alternative hypothesis that there was a 
significant difference between males and females using biologically active supplements.  
2) The same stage, the null hypothesis was rejected, thus accepted the alternative hypothesis 
that there was a statistically significant difference in knowledge between biologically active 
supplement consumers and non-consumers. 
3) In this stage, the null hypothesis was failed to reject. Thus, the null hypothesis was 
accepted that indicated a strong association between the use of BAS and government 
regulation.   
5.1 Descriptive statistics of study population 
This study examined the regulation and association of sociodemographics, health status, 
socioeconomics and fundamental subject on biologically active supplement use among study 
populations. According to these statements, data stratified by gender, knowledge as 
independent variables, and using BAS as dependent variables to access the study's purpose. 
Each variable and respondents' answers were tabulated between consumer and non-consumer 
groups then recorded in percentage/frequencies. The total number of participants in this 
study were 372, and the questionnaire rate was 95%. Among them were 30.1% males and 
two times more females were 69.9%. This result is quite similar to the result of studies in the 
Lebanese population [48].  
Mostly part of the consumers was female consumers (72.0%) than male (28%). This 
high proportion of consumers being females may be due to the higher percentage of females 
participated in the study. The same indicator had shown in this study [49].  
In Australia, using BAS proportion among the population was female 43.2%, and males 
were 20.1% in 2014–2015 [50]. The BAS use proportion was 44.53% among the South 
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Korean population in 2015 compared to women who were more likely to use BAS than men 
by 38.9% [51].  
According to the American Community Survey data source, by 2016, BAS's use in the 
US was 68.0%, and the consumer confidence interval was high, with 84.0% [52]. Using BAS 
was more prevalent in developed countries due to the legal protection for the BAS 
population [53] and the high economic level of countries guiding to BAS's high use.  
The age ranged from 30 to 59 years, and the mean age was 30.9. The majority part of the 
consumers had high education, and those were urban residents. This is characteristics also 
comparable to this study [48].  
This study participated 31.7% HCWs, mostly doctors and pharmacists. Their opinion 
attitude towards BAS was positive, and more than half of them were consumers. They were 
strongly associated between BAS and HCWs with OR=2.09, 95% CI 0.68 to 5.82, and a 
trend for higher dietary supplement use. This finding indicated that HCWs could influence 
the regulation of the BAS sector in the Kyrgyz Republic. 
Consumers group allocated people with higher education, middle income, and a 
medium level of workers. Their income can freely consume BAS products, which promote 
health; this is similar to studies [51]. People's attitude towards BAS is positive. However, 
non-consumers were insufficient knowledge regarding BAS products and were in negative 
opinion to use BAS. The BAS use percentage has highest among the study population with 
regular health, where the participants who know their health conditions were the least likely 
to use BAS. 
Substantially part of consumers had benefited from taking of BAS and satisfied. 
Reversely non-consumers were dissatisfied with the BAS products. Most consumers parallel 
used BAS with medicines, whereas particularly have had side effects from BAS. In such 
cases, they individually took action as usual. One research reported that consumers used 
BAS because they believed in the health benefits, even if scientific evidence indicated no 
effects [54]. Thus, BAS, including herbs, can be dangerous when combined with medicines. 
Due to the study results in Kyrgyzstan, BAS's quality does not meet the hygienic 
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requirements of food safety. The research revealed that almost all study populations not 
familiar with existing government regulations on BAS in the Kyrgyz Republic. The 
population also suggested having control on quality, safety, effective and knowledge 
awareness on BAS products. Insufficient government regulation of the BAS products 
marketing may result in an inaccurate recommendation to BAS consumers [55]. 
In Kyrgyzstan, BAS is not recommended for the general population because the public did 
not have enough knowledge and the proper attitude toward BAS. Besides, false and 
exaggerated propaganda leads consumers to distrust the BAS. Therefore, the government 
regulators and scientific academy should strengthen the BAS quality control, industry sector, 
and BAS products marketing system to lead the consumers to correct way use of BAS 
products. Also, BAS-related information sources should be under the government's control 
(widely public advertising by various publicity channels) to avoid false and exaggerated 
propaganda and help people better understand BAS. The same research finding among the 
Chinese population in 2012 [56]. 
In Kyrgyzstan 90% of BAS products are imported from other countries, respectively, 
their price more expensive than domestic. Consequently, affordability the primary function 
play for using BAS products, and it is directly related to the income of the population. The 
study showed that population affordability to BAS was at a low-income level. 
BAS usage varies by age, gender, geographical location, education, income, and health 
status. For instance, the results showed that widespread use of BAS products by gender 
males (M=1.40, SD=0.492) used more than females (M=1.23, SD=0.420) BAS products, 
t(370)=3.49, p< .001, Cohen's D=0.37. According to this result, we can compare the 
differential of using BAS between males and females that BAS use in males was 
significantly higher than in females. Cohen's effect size represents a 'medium' effect size 
between two groups that differ by 0.37. This result was consistent with the other researcher's 
results [51]. Also, females living in urban areas and with a higher education level and middle 
income were more likely to use BAS products. Consistent with other surveys [57]. 
Demographic characteristics between males and females were significantly related to the 
76 
 
overall prevalence of BAS use. For instance, both female and male groups had unhealthy 
subjective, and they may have more health consciousness and more health problems, 
resulting in higher BAS use. Urban residents with higher income have more accessibility for 
purchasing BAS products. 
Finding results indicated different use of BAS by gender. Mostly females pay more 
attention to packages than males; it means that BAS should comply with labeling, packing, 
and composition on health claims. More males familiar with government regulation on BAS. 
Both groups of consumers were satisfied with taking BAS products, while males do not use 
BAS were not satisfied and disagree. However, both groups experienced adverse events from 
taking it. It is directly related to the quality control of BAS products throughout the 
government regulation system. According to finding between females and males, statistical 
was significantly different using BAS and insufficient knowledge using BAS products. 
This study revealed misperceptions and misconceptions regarding the safety of BAS among 
the population in the Kyrgyz Republic. Most respondents falsely believed that BAS is safe to 
use because the ingredients are "natural sources" and no risk to the general population, and 
they must be safe to be sold in Kyrgyzstan. Similar research conducted in the USA 
population and the same beliefs revealed that BAS products are harmless [58].   
The study results showed that BAS consumers frequently received information from the 
medical doctors and relatives' advice and families through the internet. Other sources are 
followed by friends' recommendations, advertising on TV/public places, fitness trainers, and 
cosmetologist recommendations. The majority of respondents purchase BAS products in 
pharmacies, particular stores, and online stores. In Kyrgyzstan's overall distributed network 
market, distributors play the leading role in selling BAS products. Most distributors are non-
professionals who should take responsibility for public health. Therefore side-effects and 
misusing BAS products were relevant issues among the population. Mainly part of 
consumers chosen the BAS products based on its brands and country of origin.   
During the survey, the majority population expressed in this study wanted to know more 
about the quality, safety, and efficacy of the BAS products. These findings underscore the 
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need to raise public awareness regarding BAS use. Also evaluated knowledge of physicians, 
pharmacists, and nurses through a questionnaire regarding BAS products gave a low level of 
knowledge on BAS mechanisms of action, interactions, safety, and overall herbal medicines 
[59]. Therefore, healthcare professionals involving physicians, pharmacists, dietitians, and 
other HCWs need to improve their professional skills consequently the public regarding the 
safety, quality, and efficacy of BAS in specific conditions as potential interactions with 
pharmacologic treatments. 
5.2. Knowledge, Attitudes towards BAS among consumers and non-consumers 
The study defined statistical significance between consumer and non-consumer groups 
using BAS products and overall knowledge. Thus, the null hypothesis rejected a difference 
in knowledge and using BAS products among consumer and non-consumer groups. 
Reversely, interesting research was found. For instance, 73,38% of the study population 
consumers do not know about supplementation, and 58.59% of the non-consumer group 
knows about supplementation. This research was designated in a study among the European 
population using biologically active supplements regarding knowledge [60].  
The other regarding knowledge statements were also statistically significant, that means 
it was a difference of using BAS between: "Distinguish BAS products from medicines 
(p=0.001); Benefits after taking BAS products (p=0.001); Combine the use of BAS products 
with medicines (p=0.001); Effectiveness (p=0.001); Safety use of BAS among consumers 
and non-consumers (p=0,001); Comply labeling health claims (p=0.01); The government 
regulation on BAS and Consumer satisfaction (p=0.001)". 
When conducting the questions based on knowledge, consumers indicated better knowledge 
of BAS effectiveness and regulation than non-consumers. For distinguishing BAS products 
from medicines, most consumers answered that item correctly as being yes. Mainly more 
users correctly answered "no" to labeling and packing BAS products should comply with 
label health claims. 
The other question like benefits after taking BAS products the majority of users correctly 
answered yes than non-users. Moreover, the other statements, like combining BAS products 
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with medicines and safety to use BAS products, mostly respond among consumers and non-
consumers, were made not know or never used. This defined that both consumer and non-
consumer were unclear about the proven combined use of BAS and safety of BAS products. 
The statement "The quality of BAS products sufficient to make consumer satisfaction in the 
Kyrgyz Republic" mostly replied "yes." All statements of responses were designated 
statistically significant at p>0.05. 
5.3. The main concept attitude towards on BAS among the study population 
The central concept of the study has to assess specific characteristics regarding BAS 
products. For instance, BAS products, awareness of BASs, prevalence type of BAS, and 
reason to consume or motivating factors. The definitions and categorization of biologically 
active supplements are not standardized [61]. Therefore, lack of standardization makes it 
difficult to compare prevalence estimates between populations. This study represented an 
assessment regarding BAS products' definition among the population that majority of people 
understood the term of BAS products as a food supplement and a few people considered as a 
kind of medicine and usual chemistry.  
According to the notion based on BAS, the population has chosen the type of the BAS 
as vitamin and minerals (48.4%), proteins (23.7%), energizers (18.8%), and a few 
proportions of the population prefer to use as herbal and Phyto preparations. Interestingly, a 
study conducted by US researchers estimated the study population based on the consumption 
of single dietary supplement type by category and was statistically significant frequency 
difference between male and female. It has been implied that more females preferred 
vitamins and complexes of vitamins/minerals than males. However, the type of energizers 
preferred more males than females. The other types of BAS products as herbal and phyto 
preparations fewer people have chosen. These research findings underscore the use type of 
BAS by gender [62].  
Most people used or preferred BAS products in capsules, tablets, herbal preparation, 
and syrup. The indicated consumption reason for the BAS products among the population 
and people were used in different motivating factors. For instance, most of the population 
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(67.7%) used as toning the body and 9.1% to prevent diseases, striving for longevity and 
beauty. This study showed statistically significant (p<0.05) reason for BAS consumption 
between males and females that underscore different consumption reasons used by gender: 
for instance, Improving Sport performance for males and health improvement (41.6%) for 
females. Moreover, both groups were used high prevalence in toning of the body (45.5%F 
and 29.2%M). Comparison of these studies indicated that BAS consumption was used in a 
specific way, which was more useful for the population [63]. 
5.4. Biologically active supplement usage patterns among study population 
A significant proportion of the study on BAS showed that BAS use among the study 
population has been consistent with particular sociodemographic characteristics like females, 
a higher education level, and income. For instance, women were more likely to use BAS 
than men [64]. According to the study results, sociodemographic characteristics did not show 
any association between BAS use and demographic characteristics like gender, age, 
occupation, and income. However, people with higher education tend to have an occupation 
that provides higher income. Other research work indicated that the lowest social class tends 
to have less balanced and less healthy diets [58]. Like this, lower social class may not 
accommodate the necessary things in life, such as using biologically active supplements.  
Between education, Availability, and Government regulation, there was a rending for higher 
BAS use in those who had education, availability to BAS products and government 
regulation on BAS. Education was a more robust social determinant of diet than availability 
and government regulation. Thus, people with higher education tend to have availability, 
which provides government regulation on BAS products.  
People with health status, Safety of BAS products,and Attitude towards BAS were 
associated with BAS consumption and statistically significant. Effectiveness of BAS 
products was also strongly associated with BAS consumption. Findings of this association, 
each of these characteristics with BAS products' consumption, indicated contribution 
marginally to BASs among consumers to be good health. They believed to ensure a positive 
effect on health and well-being. These findings were mostly consistent across education 
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level, regulation, availability, safety, attitude towards BAS, and health status. Other variables 
showed less likelihood to consume dietary supplements. 
5.5. Limitation of the study 
There were several limitations in this study. The main limitation of this study is that 
survey data was self-reported, thus responses may be dishonest. Respondents  may have 
misunderstood the content of the survey on BAS. Firstly, general questions were asked 
regarding BASs in the questionnaire, not detailed information, such as subcategories of 
multivitamins and multiminerals ect. Secondly, for the consumer during the previous month 
may not represent the practices use of BAS, which may underestimate BAS use. In addition, 
unlike other studies examining BAS, this study did not cover health conditions, such as 
diabetic, cancer ect. The information that was used in this study could have been useful to 



















CONCLUSION AND RECOMMEDNATION 
This study's objective was to look at selected consumers and non-consumer towards 
BAS and its regulatory system in the Kyrgyz Republic. Conducted comparative study of the 
regulation system in Kyrgyzstan and the Republic of Korea. According to the research 
statement, the conclusion and recommendation consist of two parts:  
Ι. Regarding the questionnaire survey, scrutiny results showed that the use of 
biologically active supplements is prevalent (72%). It was aged between 40 and 59 years, 
and the central part of consumers was female (69.9%). BAS use is associated with health 
status, education, government regulation, safety, and effectiveness. Especially people with 
higher education level and having a healthier more likely to consume BAS in an appropriate 
way. The current results emphasize the compelling need for spreading public awareness in 
the Kyrgyz Republic regarding BAS products. Consumers should be advised that BAS 
products may not always be beneficial and can cause serious side effects; therefore, 
consulting with healthcare professionals before starting any supplement. All 
multidisciplinary healthcare structure members should also clearly understand the potential 
hazards and benefits of BAS therapies and encourage consumers' disclosure of alternative 
medicine. 
A collaborative effort of governmental structure, health educational institutions is 
recommended to educate, regulate, and promote the appropriate and safe use of biologically 
active supplement products.  
ΙΙ. In the second part about a political study on BAS and HFF in Kyrgyzstan and the 
Republic of Korea, we studied to distinguish the difference between the two countries and 
determine the appropriate functions for regulating the BAS in Kyrgyzstan.  
The regulation system on BAS in the Kyrgyz Republic is not well adjusted; the government 
needs to make the BAS market more transparent. Also, conformity of confirmation for 
quality of BAS product procedures does not reply to the international requirement's BAS 
demands. These findings recommend to the Ministry of Health following the points: 
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1) The registration of the BAS products in the country suggests establishing new BAS 
labeling requirements that imply a unique code on the package, a sequence of 
symbols. This unique system will be single and intended to solve technical 
regulation's following urgent problems: - create an automatic product tracking 
system; - protect consumers from counterfeiting; - fight against unscrupulous 
companies supplying counterfeit products to the market. It will allow the buyer to 
obtain the BAS's full information by pointing at a special scanner's unique code on a 
mobile device. It will give information about the product by whom and when the 
goods were produced, through what channels they entered the distribution network 
2) In Korea, the MFDS has given authority to keep manufacturers and distributors 
responsible for providing all evidence regarding their products' advertised claims by 
developing a system to substantiate claims. This priority can be a help to regulate 
counterfeit substances and the quality of BAS in Kyrgyzstan. 
3) In Korea regulation system on HFF provided health claims under the HFFA 
regarding nutrition, reductions in disease risk, and other functions. It helps to control 
the relationship between the consumption of HFFs and the reduced risk of 
developing a disease or health-related condition in Kyrgyzstan. 
4) In Korea, the safety evaluation is checked very carefully following these criteria: 
quantity of HFF for consumption, human studies’ results, and results of nutritional 
evaluation and bioavailability. This is an essential factor that can be used as these 
criteria for safety on food procedures in the Kyrgyz Republic system. 
Progress can be expected to improve the BAS products' quality control and safety and the 
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VIII.  APPENDIX 




Gender Whether respondent is 
male or female 
1= male  
2= female  






Measures whether a 
respondent is resident in 
an urban or rural area 
1=Urban  
2=Rural 
Education    
 
Whether 
the respondent had 
formal education 
1= Primary/secondary school 
2=Professional,technical college 
3= High graduate 
Employment Whether the respondent 
has work or not 
1=Working 
2=Not working 
3=Temporary not working 
Health status 
 
Health condition of 
respondents 
1= Unhealthy  
2= Normal 
3= Healthy 
Occupation   
 
Whether the respondent 
specialized  
1=Doctors, nurses, pharmacists  
2=Government employers and 
private entrepreneurs 
3=Housewives, pensioners and 
students  
Income Relation income and 
using of BAS 
A continuous 
quantitative measure 
Variables: based on BAS 
Attitude to BAS Respondent’s attitude to 




Type of BAS 
 
The respondent that 







5=Kind of medicine 
6=I don’t know 
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Origin of BAS 
 
Assessment the quality 
of domestic and import 




of BAS from medicines 
Whether the respondent 
know difference  
1=Yes 
2=No 
Use of BAS  Whether the respondent 
use of BAS or not 
1=Yes  
2=No 
Duration of  taking BAS To know how long the 
respondent is using 
BAS (for a year) 
1=One  course  
2=More than one course  
3=Other 
Benefits from using BAS  The respondent take 
benefit from using BAS 
1=Yes 
2=No 
3=Difficult to answer 
BAS composition  
 
 
Which kind of BAS 
composition the 
respondent use or prefer  










Form of BAS that the 
respondent use or prefer 
1=Tablet     
2=Capsule      
3=Syrup      
4=Ointment      
5=Gel  
6=Powder          
7= Herbal preparations 
8= All above 
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Motivation to consume of 
BAS 
 
Whether the respondent 
has purpose for using 
BAS 
1=Toning the body 





5=Losing Weight  
6=Keeping Weight  
7=Striving for longevity and 
beauty 
8=Prevention of disease 
9=Self-medication of diagnosed 
diseas 
10=Meal Replacement  
Equivalent 
11=Malaise 
Use BAS with medicines 
(parallel) 









Whether the respondent 










3=Difficult to answer 
Availability and 
accessibility  
Whether the respondent 
have difficulties to 




Packaging, labeling and 
content of the BAS 
BAS should comply 




Information source Importance information 
source that people can 
trust 
1=Doctor recommendation  
2=Family recommendation  
3=Friends recommend. 
4=Positive feedback on the 
internet  
5=Advertising on TV/Inter 
6=Advertises on public place  
7=Fitness trainer recomm. 




Affordability Willing to spend money 
for BAS in som 
A continuous 
quantitative measure 
Purhcase place Place that is reliable for 
consumers  
1=Pharmacy  
2=Special store  
3=Beaty salon  




Government regulation The government 
regulates the BAS 
1=Yes 
2=No 
3=Difficult to answer 
Importancce of government 
regulation  
Need the regulation for 
BAS in the country 
1=Yes 
2=No 
3=Difficult to answer 
Side effects  Experience of adverse 
event after taking BAS 
1=Yes 
2=No 
Adverse events If got adverse events, 




Satisfaction with quality of 
BAS 
The respondent 
satisfied  with the 
quality of BAS  
1=Satified  
2= Dissatisfied 
Important factor for 
choosing BAS 
The respondent can 
choose BAS according 
the factors 
1=Brand of company 
2=Price 
3=Country of origin 
4=Advertising 
5=Quality 
Assessment for network 
marketing system in KG 
The respondent assess 
the network system in 
Kyrgyzstan 





2. Ethical Authorizationf  













도입: 많은 나라에서 생물학적 활성 보충제 시장이 성장하고 있다. 그러나 생물학적 활성 
보충제의 소비에 대한 데이터는 여전히 제한적이다. 
관련 시장에서 키르기즈 인구의 생물학적 활성 보충제 사용이 증가하고 검출 기준 미달 및 위조, 
변조 사례가 확대되는 것은 생물학적 활성 보충제에 관한 규제 시스템의 위기와 인식 부족 
등이며. 이런 문제들이 이 연구에 흥미를 갖게 해주어 연구하게 되었다. 
이번 연구는 키르기즈 인구 중 생물학적 활성 보충제에 대한 소비자의 태도를 파악하고 BAS에 
대한 지식을 평가하며, 키르기즈의 규제 체계를 대한민국과 비교 연구하기 위한 것이다. 
연구소재와 연구방법: 이 연구의 일반적인 방법은 정성적 접근법을 사용해 왔다. 연구 목표를 
달성함에 있어 1차 및 2차 연구 소재로 수집된 데이터가 사용되었다. 연구 모집단의 소비자 및 
비소비자 간의 생물학적 활성 보충제 사용에 기초한 온라인 설문지를 통해 수집된 1차 설문의 
주요 참가 인원은 총 372명이었다. 2차 연구 소재로는 BAS와 HFF의 규제 시스템에 대한 
키르기즈과 한국 정부의 연구 자료와 필요한 문서를 사용했다. 
결과: 인구대비 생물학적 활성 보충제 사용의 유병률이 높은 것으로 조사되었고 참가자의 
72.0%는 소비자였고 28.0%는 비소비자였다.  이 중 여성은 69.9%, 남성은 30.1%로 나타났다. 
확인: 생물학적 활성 보충제를 사용하는 남성과 여성은 통계적으로 유의미한 차이가 있고, 
소비자와 비소비자 간의 유의미한 지식 차이, 그리고 생물학적 활성 보충제 사용에 대한 정부 
규제와 강한 연관성이 있는 것으로 보인다. 한국의 HFF 규제 연구는 키르기즈의 BAS 규제를 
위한 적절한 기능을 권고한다. 
결론: 키르기즈 공화국에서 생물학적 활성 보충제에 대한 대중의 인식을 확산시킬 필요가 
있다는 것이 강조된다. BAS 제품이 항상 이롭지 않을 수 있고 심각한 부작용을 일으킬 수 
있으므로, 소비자들은 사용하기 전에 의료 전문가와 상담해야 한다. 모든 다분야 의료 구조 
구성원은 BAS 치료의 잠재적 위험과 이익을 명확하게 이해해야 한다. 또한 정부는 생물학적 
활성 보충제 시장에 대한 등록 절차와 유통 경로를 보다 투명하게 하고 엄격한 규제 체계를 만들 
필요가 있다. 
키워드: 생물학적 활성 보충제, 건강 기능성 식품, 규제, 치료제. 
